Details of Drug

Drug General Information (ID: D0375)
Drug Name	Cobicistat
Drug Type	Small molecule
Drug Synonymous	1004316-88-4; Cobicistat (GS-9350); GS 9350; GS-9350; UNII-LW2E03M5PG; Cobicistat,GS-9350; CHEBI:72291; LW2E03M5PG; Tybost; thiazol-5-ylmethyl (2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanamido)-1,6-diphenylhexan-2-ylcarbamate; 1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2S)-2-({[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}amino)-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl]carbamate; 1,3-thiazol-5-ylmethyl Click to Show/Hide
Disease Class	1C60-1C62: Human immunodeficiency virus disease
Therapeutic Class	Antiviral Agents
Structure
Structure	3D Structure		2D Structure
Formula	C40H53N7O5S2
InChI	1S/C40H53N7O5S2/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49)/t32-,33-,36+/m1/s1
InChIKey	ZCIGNRJZKPOIKD-CQXVEOKZSA-N
Canonical SMILES	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5
External Link
	Pubchem ID	25151504
	CAS Number	1004316-88-4
	CHEBI ID	72291
	TTD ID	D02VJP
	INTEDE ID	DR0364

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects BM010 Transporter inhibition BM017 CYP450 enzyme inhibition BM019 UGT inhibition BM022 CYP450 enzyme induction BM038 Additive CNS depression effects
Relation Graph

Full list of drugs interacting with Cobicistat
Affected cellular transport
	Transporter inhibition					Drug Num: 24
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0194		Bosentan	C27H29N5O6S	104865	Major		Inter Info	[16], [25], [26]
D0171		Berotralstat	C30H26F4N6O	137528262	Major		Inter Info	[74]
D0551		Edoxaban	C24H30ClN7O4S	10280735	Major		Inter Info	[25], [82], [83]
D0562		Eluxadoline	C32H35N5O5	11250029	Major		Inter Info	[16], [85], [86]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[15], [149]
D1388		Relugolix	C29H27F2N7O5S	10348973	Major		Inter Info	[154]
D1408		Riociguat	C20H19FN8O2	11304743	Major		Inter Info	[15], [16], [345], [18]
D0303		Cerivastatin	C26H34FNO5	446156	Moderate		Inter Info	[15], [16], [25], [223], [83], [513]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[20]
D0109		Artesunate	C19H28O8	6917864	Moderate		Inter Info	[20]
D0176		Betrixaban	C23H22ClN5O3	10275777	Moderate		Inter Info	[541]
D0700		Fostemsavir	C25H26N7O8P	11319217	Moderate		Inter Info	[544]
D0726		Glecaprevir	C38H46F4N6O9S	66828839	Moderate		Inter Info	[545]
D0963		Lusutrombopag	C29H32Cl2N2O5S	49843517	Moderate		Inter Info	[20]
D1396		Revefenacin	C35H43N5O4	11753673	Moderate		Inter Info	[549], [550], [551]
D1436		Sacubitril	C24H29NO5	9811834	Moderate		Inter Info	[15], [549], [550]
D1532		Talazoparib	C19H14F2N6O	135565082	Moderate		Inter Info	[16], [554]
D1710		Voxilaprevir	C40H52F4N6O9S	89921642	Moderate		Inter Info	[558]
D0491		Digoxin	C41H64O14	2724385	Moderate		Inter Info	[15], [575], [20]
D0686		Fluvastatin	C24H26FNO4	446155	Moderate		Inter Info	[15], [16], [25], [223], [83], [513]
D1301		Pitavastatin	C25H24FNO4	5282452	Moderate		Inter Info	[15], [16], [25], [223], [83], [513]
D1329		Pravastatin	C23H36O7	54687	Moderate		Inter Info	[15], [16], [25], [223], [83], [513]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[20]
D1430		Rosuvastatin	C22H28FN3O6S	446157	Moderate		Inter Info	[16], [25], [44]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 345
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0035		Alfentanil	C21H32N6O3	51263	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14]
D0036		Alfuzosin	C19H27N5O4	2092	Major		Inter Info	[15], [16], [17], [18], [19]
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[20]
D0096		Apixaban	C25H25N5O4	10182969	Major		Inter Info	[15], [16], [21], [18]
D0108		Artemether	C16H26O5	68911	Major		Inter Info	[15], [16], [22]
D0128		Avanafil	C23H26ClN7O3	9869929	Major		Inter Info	[15], [18], [23]
D0133		Axitinib	C22H18N4OS	6450551	Major		Inter Info	[15], [16], [24], [18]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[20]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Major		Inter Info	[15], [16], [27], [18]
D0215		Budesonide	C25H34O6	5281004	Major		Inter Info	[28], [15], [16], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41]
D0226		Butorphanol	C21H29NO2	5361092	Major		Inter Info	[42]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[15], [16], [43], [18]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[15], [18], [46]
D0336		Cilostazol	C20H27N5O2	2754	Major		Inter Info	[16], [47], [48], [49]
D0342		Cisapride	C23H29ClFN3O4	6917698	Major		Inter Info	[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [20], [61], [62]
D0364		Clopidogrel	C16H16ClNO2S	60606	Major		Inter Info	[15], [63], [64], [65], [66], [67], [68]
D0006		Abemaciclib	C27H32F2N8	46220502	Major		Inter Info	[69]
D0129		Avapritinib	C26H27FN10	118023034	Major		Inter Info	[16], [70]
D0161		Benzhydrocodone	C25H25NO4	49836084	Major		Inter Info	[71], [72], [73]
D0202		Brexpiprazole	C25H27N3O2S	11978813	Major		Inter Info	[75]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Major		Inter Info	[76]
D0251		Capmatinib	C23H17FN6O	25145656	Major		Inter Info	[77]
D0389		Copanlisib	C23H28N8O4	135565596	Major		Inter Info	[78]
D0408		Daclatasvir	C40H50N8O6	25154714	Major		Inter Info	[16], [79]
D0436		Deflazacort	C25H31NO6	189821	Major		Inter Info	[16], [80]
D0543		Duvelisib	C22H17ClN6O	50905713	Major		Inter Info	[81]
D0555		Elagolix	C32H30F5N3O5	11250647	Major		Inter Info	[84]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Major		Inter Info	[87]
D0571		Enfortumab vedotin	NA	NA	Major		Inter Info	[16], [88], [89], [90]
D0577		Entrectinib	C31H34F2N6O2	25141092	Major		Inter Info	[15], [16], [91]
D0590		Erdafitinib	C25H30N6O2	67462786	Major		Inter Info	[92]
D0638		Fedratinib	C27H36N6O3S	16722836	Major		Inter Info	[16], [93]
D0683		Fluticasone	C22H27F3O4S	5311101	Major		Inter Info	[94], [95], [96], [97], [29], [98], [99], [100], [101], [102], [103], [104], [105], [34], [106], [107], [108], [36], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130]
D0684		Fluticasone (nasal)	C22H27F3O4S	5311101	Major		Inter Info	[117], [118], [130]
D0720		Gilteritinib	C29H44N8O3	49803313	Major		Inter Info	[131]
D0725		Glasdegib	C21H22N6O	25166913	Major		Inter Info	[132]
D0739		Grazoprevir	C38H50N6O9S	44603531	Major		Inter Info	[15], [16], [133]
D0866		Istradefylline	C20H24N4O4	5311037	Major		Inter Info	[134]
D0868		Ivabradine	C27H36N2O5	132999	Major		Inter Info	[15], [16], [135], [18]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[136]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Major		Inter Info	[15], [16], [137]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[138]
D0901		Lemborexant	C22H20F2N4O2	56944144	Major		Inter Info	[15], [139]
D0953		Lorlatinib	C21H19FN6O2	71731823	Major		Inter Info	[140]
D0962		Lurbinectedin	C41H44N4O10S	57327016	Major		Inter Info	[141]
D1124		Neratinib	C30H29ClN6O3	9915743	Major		Inter Info	[142], [15], [143]
D1167		Olaparib	C24H23FN4O3	23725625	Major		Inter Info	[15], [16], [144], [18]
D1169		Oliceridine	C22H30N2O2S	66553195	Major		Inter Info	[145], [146]
D1189		Osilodrostat	C13H10FN3	44139752	Major		Inter Info	[16], [147]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[148]
D1214		Palbociclib	C24H29N7O2	5330286	Major		Inter Info	[150]
D1242		Pemigatinib	C24H27F2N5O4	86705695	Major		Inter Info	[16], [151]
D1306		Polatuzumab vedotin	NA	NA	Major		Inter Info	[152]
D1324		Pralsetinib	C27H32FN9O2	129073603	Major		Inter Info	[153]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[16], [155]
D1409		Ripretinib	C24H21BrFN5O2	71584930	Major		Inter Info	[15], [156]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[16], [157]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[15], [158]
D1496		Sonidegib	C26H26F3N3O3	24775005	Major		Inter Info	[159]
D1538		Tazemetostat	C34H44N4O4	66558664	Major		Inter Info	[160]
D1663		Ubrogepant	C29H26F3N5O3	68748835	Major		Inter Info	[161]
D1666		Upadacitinib	C17H19F3N6O	58557659	Major		Inter Info	[162]
D1688		Venetoclax	C45H50ClN7O7S	49846579	Major		Inter Info	[164]
D1709		Voxelotor	C19H19N3O3	71602803	Major		Inter Info	[165]
D1718		Zanubrutinib	C27H29N5O3	135565884	Major		Inter Info	[166]
D0376		Cobimetinib	C21H21F3IN3O2	16222096	Major		Inter Info	[15], [167], [18]
D0380		Colchicine	C22H25NO6	6167	Major		Inter Info	[168], [169], [170], [15], [16], [171], [172], [173], [174], [175], [176], [177], [178], [38], [18], [39], [179], [180], [181], [182], [183], [184], [185]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[15], [18], [186]
D0402		Cyclosporine	C62H111N11O12	5284373	Major		Inter Info	[187]
D0424		Darifenacin	C28H30N2O2	444031	Major		Inter Info	[15], [188], [189], [18]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Major		Inter Info	[15], [18], [190]
D0494		Dihydroergotamine	C33H37N5O5	10531	Major		Inter Info	[191], [192], [193], [194], [16], [53], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[20]
D0511		Docetaxel	C43H53NO14	148124	Major		Inter Info	[215], [15], [16], [216], [217], [18], [218], [219], [220], [221]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[15], [222], [18]
D0536		Drospirenone	C24H30O3	68873	Major		Inter Info	[15], [16], [223], [224], [83], [39], [225]
D0557		Eletriptan	C22H26N2O2S	77993	Major		Inter Info	[226]
D0559		Eliglustat	C23H36N2O4	23652731	Major		Inter Info	[15], [16], [227], [18]
D0585		Eplerenone	C24H30O6	443872	Major		Inter Info	[15], [228], [18]
D0592		Ergometrine	C19H23N3O2	443884	Major		Inter Info	[202], [206], [212]
D0593		Ergotamine	C33H35N5O5	8223	Major		Inter Info	[191], [192], [193], [194], [16], [53], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214]
D0597		Erythromycin	C37H67NO13	12560	Major		Inter Info	[229], [230]
D0612		Eszopiclone	C17H17ClN6O3	969472	Major		Inter Info	[231], [232], [53], [233], [234]
D0629		Everolimus	C53H83NO14	6442177	Major		Inter Info	[15], [235], [236], [18]
D0646		Fentanyl	C22H28N2O	3345	Major		Inter Info	[15], [237], [238], [239], [18], [240], [13]
D0655		Fesoterodine	C26H37NO3	6918558	Major		Inter Info	[15], [18], [241], [242]
D0664		Flecainide	C17H20F6N2O3	3356	Major		Inter Info	[20]
D0665		Flibanserin	C20H21F3N4O	6918248	Major		Inter Info	[243]
D0745		Guanfacine	C9H9Cl2N3O	3519	Major		Inter Info	[16], [244]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[245], [246], [247], [248], [249]
D0772		Hydrocodone	C18H21NO3	5284569	Major		Inter Info	[71], [72]
D0785		Ibrutinib	C25H24N6O2	24821094	Major		Inter Info	[15], [250], [18]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[251]
D0845		Irinotecan	C33H38N4O6	60838	Major		Inter Info	[252], [15], [16], [253], [254], [255], [256]
D0846		Irinotecan (liposomal)	C33H38N4O6	60838	Major		Inter Info	[16], [253], [254]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Major		Inter Info	[257]
D0869		Ivacaftor	C24H28N2O3	16220172	Major		Inter Info	[15], [16], [258], [259], [260], [261]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Major		Inter Info	[15], [18], [262]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[263], [264]
D0920		Levomilnacipran	C15H22N2O	6917779	Major		Inter Info	[265]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[15], [266], [18]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Major		Inter Info	[264]
D0956		Lovastatin	C24H36O5	53232	Major		Inter Info	[267], [268], [269], [270], [271], [272], [273], [274], [53], [275], [276], [277], [278], [279], [280], [281], [282], [283], [284], [285], [286], [287], [288], [289], [290], [291], [292], [293], [294], [295], [296], [297], [298], [299], [300], [301], [302], [303], [304], [305], [306], [307], [308], [309], [310], [311]
D0959		Lumateperone	C24H28FN3O	21302490	Major		Inter Info	[312]
D0961		Lurasidone	C28H36N4O2S	213046	Major		Inter Info	[15], [16], [313], [18]
D0966		Macitentan	C19H20Br2N6O4S	16004692	Major		Inter Info	[314]
D1037		Methylergometrine	C20H25N3O2	8226	Major		Inter Info	[202], [206], [212]
D1041		Methylprednisolone	C22H30O5	6741	Major		Inter Info	[315], [17], [316], [317], [318], [319], [320], [321]
D1043		Methysergide	C21H27N3O2	9681	Major		Inter Info	[202], [206], [212]
D1062		Midostaurin	C35H30N4O4	9829523	Major		Inter Info	[322], [323]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[324], [325]
D1104		Naloxegol	C34H53NO11	56959087	Major		Inter Info	[15], [16], [326], [18]
D1136		Nilotinib	C28H22F3N7O	644241	Major		Inter Info	[15], [18], [327]
D1138		Nimodipine	C21H26N2O7	4497	Major		Inter Info	[328]
D1203		Oxycodone	C18H21NO4	5284603	Major		Inter Info	[15], [16], [329]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[330], [331]
D1232		Pazopanib	C21H23N7O2S	10113978	Major		Inter Info	[15], [18], [332]
D1290		Pimavanserin	C25H34FN3O2	10071196	Major		Inter Info	[333]
D1313		Ponatinib	C29H27F3N6O	24826799	Major		Inter Info	[15], [16], [334]
D1353		Propafenone	C21H27NO3	4932	Major		Inter Info	[20]
D1368		Quetiapine	C21H25N3O2S	5002	Major		Inter Info	[335], [336], [337], [338], [339], [340], [341], [342], [343]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[20]
D1383		Ranolazine	C24H33N3O4	56959	Major		Inter Info	[15], [16], [344], [18]
D1399		Rifabutin	C46H62N4O11	135398743	Major		Inter Info	[16], [25], [82], [44]
D1417		Rivaroxaban	C19H18ClN3O5S	9875401	Major		Inter Info	[15], [16], [25], [18], [346]
D1434		Ruxolitinib	C17H18N6	25126798	Major		Inter Info	[347]
D1440		Salmeterol	C25H37NO4	5152	Major		Inter Info	[15], [16], [348], [18]
D1465		Sildenafil	C22H30N6O4S	135398744	Major		Inter Info	[349], [350], [351], [352], [353], [354], [20], [355], [356]
D1466		Silodosin	C25H32F3N3O4	5312125	Major		Inter Info	[15], [357], [18]
D1471		Simeprevir	C38H47N5O7S2	24873435	Major		Inter Info	[15], [358], [18]
D1473		Simvastatin	C25H38O5	54454	Major		Inter Info	[267], [268], [269], [270], [271], [272], [273], [274], [53], [275], [276], [277], [278], [279], [280], [281], [282], [283], [284], [285], [286], [287], [288], [289], [290], [291], [292], [293], [294], [295], [296], [297], [298], [299], [300], [301], [302], [303], [304], [305], [306], [307], [308], [309], [310], [311]
D1476		Sirolimus	C51H79NO13	5284616	Major		Inter Info	[15], [359], [360], [361], [362], [363], [18], [364], [39]
D1491		Solifenacin	C23H26N2O2	154059	Major		Inter Info	[15], [16], [18], [241], [365]
D1524		Suvorexant	C23H23ClN6O2	24965990	Major		Inter Info	[15], [366]
D1526		Tacrolimus	C44H69NO12	445643	Major		Inter Info	[367], [368], [369], [370], [371], [372], [15], [16], [360], [373], [374], [375], [235], [376], [377], [378], [379], [380], [381], [382], [383], [384], [385], [386], [387], [388], [389], [390], [391], [392], [393], [394], [395], [396], [397], [398], [399], [400], [401], [402], [403]
D1534		Tamsulosin	C20H28N2O5S	129211	Major		Inter Info	[15], [404], [405], [406], [18]
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[408], [409], [410], [411], [412], [413], [414], [415], [416], [417], [146], [418], [419]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Major		Inter Info	[15], [16], [420], [18]
D1600		Tofacitinib	C16H20N6O	9926791	Major		Inter Info	[15], [16], [421]
D1608		Tolvaptan	C26H25ClN2O3	216237	Major		Inter Info	[15], [422], [18], [423]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[424]
D1615		Trabectedin	C39H43N3O11S	108150	Major		Inter Info	[15], [16], [425], [18], [426]
D1628		Triamcinolone	C21H27FO6	31307	Major		Inter Info	[315], [427], [428], [17], [429], [430], [431], [432], [433], [434], [435], [436]
D1632		Triazolam	C17H12Cl2N4	5556	Major		Inter Info	[437], [438], [439], [440], [441], [53], [442], [443], [444], [445], [446], [447], [448], [449], [450], [451], [452], [453], [454], [455], [456], [457], [458], [459]
D1682		Vardenafil	C23H32N6O4S	135400189	Major		Inter Info	[16], [25], [460]
D1696		Vilazodone	C26H27N5O2	6918314	Major		Inter Info	[461]
D1697		Vinblastine	C46H58N4O9	13342	Major		Inter Info	[462], [463], [464], [465], [466], [467], [252], [468], [15], [16], [469], [470], [471], [472], [473], [474], [475], [476], [477], [478], [479], [480], [481], [482], [483], [484], [485], [486], [487], [488], [18], [489], [490], [491], [492], [493], [494], [495], [496], [497], [498]
D1698		Vincristine	C46H56N4O10	5978	Major		Inter Info	[462], [463], [464], [465], [466], [467], [252], [468], [15], [16], [469], [470], [471], [472], [473], [474], [475], [476], [477], [478], [479], [480], [481], [482], [483], [484], [485], [486], [487], [488], [18], [489], [490], [491], [492], [493], [494], [495], [496], [497], [498]
D1699		Vincristine (liposome)	C46H56N4O10	5978	Major		Inter Info	[465], [487], [489]
D1700		Vinorelbine	C45H54N4O8	5311497	Major		Inter Info	[462], [463], [464], [465], [466], [467], [252], [468], [15], [16], [469], [470], [471], [472], [473], [474], [475], [476], [477], [478], [479], [480], [481], [482], [483], [484], [485], [486], [487], [488], [18], [489], [490], [491], [492], [493], [494], [495], [496], [497], [498]
D1705		Vorapaxar	C29H33FN2O4	10077130	Major		Inter Info	[15], [18], [499]
D0001		Abacavir	C14H18N6O	441300	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D0028		Albendazole	C12H15N3O2S	2082	Moderate		Inter Info	[20]
D0038		Aliskiren	C30H53N3O6	5493444	Moderate		Inter Info	[252], [16], [504], [505]
D0041		Almotriptan	C17H25N3O2S	123606	Moderate		Inter Info	[506]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[20]
D0069		Amlodipine	C20H25ClN2O5	2162	Moderate		Inter Info	[252], [15], [16], [507], [508]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[20]
D0074		Amphetamine	C9H13N	3007	Moderate		Inter Info	[20]
D0080		Amprenavir	C25H35N3O6S	65016	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D0100		Aprepitant	C23H21F7N4O3	135413536	Moderate		Inter Info	[509], [510]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[511]
D0119		Atomoxetine	C17H21NO	54841	Moderate		Inter Info	[20]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[15], [16], [25], [223], [83], [513]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Moderate		Inter Info	[514]
D0172		Betamethasone	C22H29FO5	9782	Moderate		Inter Info	[315], [95], [28], [515], [516], [32], [17], [517], [518], [316], [102], [103], [519], [317], [318], [319], [520], [35], [521], [40], [41], [122], [522], [320], [321], [523], [524], [525], [129]
D0193		Bortezomib	C19H25BN4O4	387447	Moderate		Inter Info	[526], [527], [528]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[16], [89], [38]
D0216		Budesonide (nasal)	C25H34O6	5281004	Moderate		Inter Info	[28], [15], [16]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[529]
D0222		Buspirone	C21H31N5O2	2477	Moderate		Inter Info	[20]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[15], [530], [18]
D0267		Carvedilol	C24H26N2O4	2585	Moderate		Inter Info	[20]
D0308		Cevimeline	C10H17NOS	83898	Moderate		Inter Info	[531]
D0320		Chloroquine	C18H26ClN3	2719	Moderate		Inter Info	[15]
D0323		Chlorpheniramine	C16H19ClN2	2725	Moderate		Inter Info	[20]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[20]
D0333		Ciclesonide	C32H44O7	6918155	Moderate		Inter Info	[315], [17], [532], [533]
D0334		Ciclesonide (nasal)	C32H44O7	6918155	Moderate		Inter Info	[534], [535], [532]
D0338		Cinacalcet	C22H22F3N	156419	Moderate		Inter Info	[536]
D0349		Clarithromycin	C38H69NO13	84029	Moderate		Inter Info	[15], [16], [177], [20]
D0354		Clindamycin	C18H33ClN2O5S	446598	Moderate		Inter Info	[537]
D0362		Clonazepam	C15H10ClN3O3	2802	Moderate		Inter Info	[20]
D0365		Clorazepic acid	C16H11ClN2O3	2809	Moderate		Inter Info	[538], [539], [20]
D0367		Clotrimazole	C22H17ClN2	2812	Moderate		Inter Info	[20]
D0370		Clozapine	C18H19ClN4	135398737	Moderate		Inter Info	[20]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[540]
D0130		Avatrombopag	C29H34Cl2N6O3S2	9852519	Moderate		Inter Info	[16]
D0425		Darolutamide	C19H19ClN6O2	67171867	Moderate		Inter Info	[542]
D0911		Levamlodipine	C20H25ClN2O5	9822750	Moderate		Inter Info	[252], [15], [16], [507], [508]
D1101		Naldemedine	C32H34N4O6	54732242	Moderate		Inter Info	[16], [546]
D1139		Nintedanib	C31H33N5O4	135423438	Moderate		Inter Info	[547]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Moderate		Inter Info	[20]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[16], [146], [548]
D1407		Rimegepant	C28H28F2N6O3	51049968	Moderate		Inter Info	[552]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[553]
D1536		Tasimelteon	C15H19NO2	10220503	Moderate		Inter Info	[555]
D1653		Troleandomycin	C41H67NO15	202225	Moderate		Inter Info	[15], [16], [177], [20]
D1660		Tucatinib	C26H24N8O2	51039094	Moderate		Inter Info	[556]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[114], [557], [127]
D0379		Codeine	C18H21NO3	5284371	Moderate		Inter Info	[559], [560], [561], [562], [563], [564], [146], [565], [566], [567], [568], [569], [570]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[15], [18], [571]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[20]
D0453		Dexamethasone	C22H29FO5	5743	Moderate		Inter Info	[15], [16], [117]
D0454		Dexamethasone (nasal)	C22H29FO5	5743	Moderate		Inter Info	[32], [517], [122]
D0455		Dexamethasone (ophthalmic)	C22H29FO5	5743	Moderate		Inter Info	[32], [517], [122]
D0457		Dexfenfluramine	C12H16F3N	66265	Moderate		Inter Info	[20]
D0466		Dextromethorphan	C18H25NO	5360696	Moderate		Inter Info	[15], [16], [572], [331], [573], [574]
D0467		Dextropropoxyphene	C22H29NO2	10100	Moderate		Inter Info	[538], [539], [20]
D0473		Diazepam	C16H13ClN2O	3016	Moderate		Inter Info	[20]
D0483		Didanosine	C10H12N4O3	135398739	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[20]
D0502		Diphenhydramine	C17H21NO	3100	Moderate		Inter Info	[20]
D0513		Dofetilide	C19H27N3O5S2	71329	Moderate		Inter Info	[576]
D0524		Doxazosin	C23H25N5O5	3157	Moderate		Inter Info	[252], [16], [577]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[20]
D0535		Droperidol	C22H22FN3O2	3168	Moderate		Inter Info	[315], [578], [15], [16], [579], [580], [581]
D0539		Duloxetine	C18H19NOS	60835	Moderate		Inter Info	[582], [583]
D0542		Dutasteride	C27H30F6N2O2	6918296	Moderate		Inter Info	[584]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D0566		Emtricitabine	C8H10FN3O3S	60877	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D0572		Enfuvirtide	C204H301N51O64	16130199	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D0595		Erlotinib	C22H23N3O4	176870	Moderate		Inter Info	[585], [586]
D0604		Estazolam	C16H11ClN4	3261	Moderate		Inter Info	[20]
D0620		Ethosuximide	C7H11NO2	3291	Moderate		Inter Info	[20]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D0640		Felodipine	C18H19Cl2NO4	3333	Moderate		Inter Info	[20]
D0641		Fenfluramine	C12H16F3N	3337	Moderate		Inter Info	[20]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[20]
D0671		Fludrocortisone	C21H29FO5	31378	Moderate		Inter Info	[315], [95], [28], [515], [516], [32], [17], [517], [518], [316], [102], [103], [519], [317], [318], [319], [520], [35], [521], [40], [41], [122], [522], [320], [321], [523], [524], [525], [129]
D0672		Flunisolide	C24H31FO6	82153	Moderate		Inter Info	[315], [95], [28], [515], [516], [32], [17], [517], [518], [316], [102], [103], [519], [317], [318], [319], [520], [35], [521], [40], [41], [122], [522], [320], [321], [523], [524], [525], [129]
D0673		Flunisolide (nasal)	C24H31FO6	82153	Moderate		Inter Info	[32], [517], [122]
D0674		Fluorometholone (ophthalmic)	C22H29FO4	9878	Moderate		Inter Info	[32], [517], [122]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[20]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[20]
D0679		Flurazepam	C21H23ClFN3O	3393	Moderate		Inter Info	[20]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[20]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Moderate		Inter Info	[509], [510]
D0707		Galantamine	C17H21NO3	9651	Moderate		Inter Info	[587]
D0713		Gefitinib	C22H24ClFN4O3	123631	Moderate		Inter Info	[585], [588]
D0750		Haloperidol	C21H23ClFNO2	3559	Moderate		Inter Info	[20]
D0773		Hydrocortisone	C21H30O5	5754	Moderate		Inter Info	[315], [95], [28], [515], [516], [32], [17], [517], [518], [316], [102], [103], [519], [317], [318], [319], [520], [35], [521], [40], [41], [122], [522], [320], [321], [523], [524], [525], [129]
D0774		Hydrocortisone (ophthalmic)	C21H30O5	5754	Moderate		Inter Info	[32], [517], [122]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Moderate		Inter Info	[15]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[589]
D0793		Imatinib	C29H31N7O	5291	Moderate		Inter Info	[590]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[20]
D0799		Indinavir	C36H47N5O4	5362440	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D0865		Isradipine	C19H21N3O5	3784	Moderate		Inter Info	[20]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Moderate		Inter Info	[20]
D0870		Ivermectin	C48H74O14	6321424	Moderate		Inter Info	[16], [591]
D0873		Ixabepilone	C27H42N2O5S	6445540	Moderate		Inter Info	[592]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Moderate		Inter Info	[20]
D0885		Lacosamide	C13H18N2O3	219078	Moderate		Inter Info	[15], [16], [593]
D0889		Lamivudine	C8H11N3O3S	60825	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D0916		Levobupivacaine	C18H28N2O	92253	Moderate		Inter Info	[16], [594]
D0927		Lidocaine	C14H22N2O	3676	Moderate		Inter Info	[16], [25]
D0955		Loteprednol (ophthalmic)	C21H27ClO5	9865442	Moderate		Inter Info	[32], [517], [122]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[20]
D0980		Maraviroc	C29H41F2N5O	3002977	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D1012		Metamfetamine	C10H15N	10836	Moderate		Inter Info	[538], [539], [20]
D1026		Methotrimeprazine	C19H24N2OS	72287	Moderate		Inter Info	[20]
D1046		Metoclopramide	C14H22ClN3O2	4168	Moderate		Inter Info	[20]
D1049		Metoprolol	C15H25NO3	4171	Moderate		Inter Info	[20]
D1054		Mexiletine	C11H17NO	4178	Moderate		Inter Info	[16], [20], [83]
D1057		Miconazole	C18H14Cl4N2O	4189	Moderate		Inter Info	[20]
D1061		Midodrine	C12H18N2O4	4195	Moderate		Inter Info	[20]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[595], [596], [146], [597], [598]
D1114		Nebivolol	C22H25F2NO4	71301	Moderate		Inter Info	[20]
D1119		Nelfinavir	C32H45N3O4S	64143	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D1128		Nevirapine	C15H14N4O	4463	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D1130		Nicardipine	C26H29N3O6	4474	Moderate		Inter Info	[20]
D1134		Nifedipine	C17H18N2O6	4485	Moderate		Inter Info	[20]
D1141		Nisoldipine	C20H24N2O6	4499	Moderate		Inter Info	[20]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[20]
D1191		Ospemifene	C24H23ClO2	3036505	Moderate		Inter Info	[599]
D1212		Paclitaxel	C47H51NO14	36314	Moderate		Inter Info	[600], [601], [15], [602], [603], [604], [605], [219]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Moderate		Inter Info	[600], [601], [15]
D1226		Paricalcitol	C27H44O3	5281104	Moderate		Inter Info	[16], [606]
D1229		Paroxetine	C19H20FNO3	43815	Moderate		Inter Info	[20]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[20]
D1293		Pindolol	C14H20N2O2	4828	Moderate		Inter Info	[20]
D1312		Pomalidomide	C13H11N3O4	134780	Moderate		Inter Info	[15], [16], [607]
D1315		Posaconazole	C37H42F2N8O4	468595	Moderate		Inter Info	[20]
D1332		Prednisolone	C21H28O5	5755	Moderate		Inter Info	[315], [95], [28], [515], [516], [32], [17], [517], [518], [316], [102], [103], [519], [317], [318], [319], [520], [35], [521], [40], [41], [122], [522], [320], [321], [523], [524], [525], [129]
D1333		Prednisolone (ophthalmic)	C21H28O5	5755	Moderate		Inter Info	[32], [517], [122]
D1334		Prednisone	C21H26O5	5865	Moderate		Inter Info	[315], [95], [28], [515], [516], [32], [17], [517], [518], [316], [102], [103], [519], [317], [318], [319], [520], [35], [521], [40], [41], [122], [522], [320], [321], [523], [524], [525], [129]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[20]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[20]
D1357		Propranolol	C16H21NO2	4946	Moderate		Inter Info	[20]
D1372		Quinine	C20H24N2O2	3034034	Moderate		Inter Info	[15], [16], [608], [609], [610], [611], [612], [613], [614], [615], [616]
D1377		Raltegravir	C20H21FN6O5	54671008	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D1378		Ramelteon	C16H21NO2	208902	Moderate		Inter Info	[617]
D1387		Regorafenib	C21H15ClF4N4O3	11167602	Moderate		Inter Info	[15], [18], [618]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[619], [620], [621], [622], [623], [624], [625]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D1413		Risperidone	C23H27FN4O2	5073	Moderate		Inter Info	[20]
D1415		Ritonavir	C37H48N6O5S2	392622	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D1424		Romidepsin	C24H36N4O6S2	5352062	Moderate		Inter Info	[626]
D1444		Saquinavir	C38H50N6O5	441243	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D1449		Saxagliptin	C18H25N3O2	11243969	Moderate		Inter Info	[16], [627]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[20]
D1504		Stavudine	C10H12N2O4	18283	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D1512		Sufentanil	C22H30N2O2S	41693	Moderate		Inter Info	[628], [629], [240]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[15], [18], [630]
D1527		Tadalafil	C22H19N3O4	110635	Moderate		Inter Info	[20]
D1533		Tamoxifen	C26H29NO	2733526	Moderate		Inter Info	[20]
D1544		Telithromycin	C43H65N5O10	3002190	Moderate		Inter Info	[15], [16], [177], [20]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[20]
D1585		Timolol	C13H24N4O3S	33624	Moderate		Inter Info	[20]
D1592		Tipranavir	C31H33F3N2O5S	54682461	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D1607		Tolterodine	C22H31NO	443879	Moderate		Inter Info	[631], [632]
D1616		Tramadol	C16H25NO2	33741	Moderate		Inter Info	[20]
D1623		Trastuzumab emtansine	NA	NA	Moderate		Inter Info	[15], [633], [18]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[634], [635], [636], [637], [638], [639], [640], [641], [642], [117], [643], [501], [644], [20], [645]
D1626		Tretinoin	C20H28O2	444795	Moderate		Inter Info	[646], [647], [648], [649], [650], [651], [652], [653], [654], [655], [656]
D1629		Triamcinolone (nasal)	C21H27FO6	31307	Moderate		Inter Info	[32], [517], [122]
D1630		Triamcinolone (ophthalmic)	C21H27FO6	31307	Moderate		Inter Info	[32], [517], [122]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[20]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Moderate		Inter Info	[657]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[15], [16], [658]
D1690		Verapamil	C27H38N2O4	2520	Moderate		Inter Info	[20]
D1706		Voriconazole	C16H14F3N5O	71616	Moderate		Inter Info	[20]
D1715		Zalcitabine	C9H13N3O3	24066	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D1720		Zidovudine	C10H13N5O4	35370	Moderate		Inter Info	[15], [16], [25], [500], [223], [501], [20], [502], [44], [503]
D1729		Zolpidem	C19H21N3O	5732	Moderate		Inter Info	[20]
D1730		Zonisamide	C8H8N2O3S	5734	Moderate		Inter Info	[659], [660]
D0007		Abiraterone	C24H31NO	132971	Minor		Inter Info	[574]
D0053		Ambrisentan	C22H22N2O4	6918493	Minor		Inter Info	[661]
D0248		Cannabidiol	C21H30O2	644019	Minor		Inter Info	[16], [662]
D0345		Citalopram	C20H21FN2O	2771	Minor		Inter Info	[663], [664]
D0518		Doravirine	C17H11ClF3N5O3	58460047	Minor		Inter Info	[665]
D0589		Eravacycline	C27H31FN4O8	54726192	Minor		Inter Info	[666]
D0696		Fosnetupitant	C31H35F6N4O5P	71544786	Minor		Inter Info	[667]
D0515		Dolutegravir	C20H19F2N3O5	54726191	Minor		Inter Info	[668]
D0516		Donepezil	C24H29NO3	3152	Minor		Inter Info	[669], [146], [670], [671]
D0599		Escitalopram	C20H21FN2O	146570	Minor		Inter Info	[663], [664]
D0797		Indacaterol	C24H28N2O3	6918554	Minor		Inter Info	[672]
D1074		Mirabegron	C21H24N4O2S	9865528	Minor		Inter Info	[673]
D1127		Netupitant	C30H32F6N4O	6451149	Minor		Inter Info	[667]
D1291		Pimecrolimus (topical)	C43H68ClNO11	6509979	Minor		Inter Info	[674]
D1394		Retapamulin (topical)	C30H47NO4S	6918462	Minor		Inter Info	[675]
D1428		Ropivacaine	C17H26N2O	175805	Minor		Inter Info	[676], [677], [678], [679], [680], [681], [682]
D1726		Ziprasidone	C21H21ClN4OS	60854	Minor		Inter Info	[683], [684], [685], [686]
	CYP450 enzyme induction					Drug Num: 25
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0255		Carbamazepine	C15H12N2O	2554	Major		Inter Info	[15], [16], [20], [44], [45]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Major		Inter Info	[15], [16], [20], [44], [45]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Major		Inter Info	[15], [16], [20], [44], [45]
D0697		Fosphenytoin	C16H15N2O6P	56339	Major		Inter Info	[15], [16], [20], [44], [45]
D1078		Mitotane	C14H10Cl4	4211	Major		Inter Info	[15], [16], [20], [44], [45]
D1265		Phenobarbital	C12H12N2O3	4763	Major		Inter Info	[15], [16], [20], [44], [45]
D1283		Phenytoin	C15H12N2O2	1775	Major		Inter Info	[15], [16], [20], [44], [45]
D1340		Primidone	C12H14N2O2	4909	Major		Inter Info	[15], [16], [20], [44], [45]
D1400		Rifampicin	C43H58N4O12	135398735	Major		Inter Info	[15], [16], [45]
D1401		Rifapentine	C47H64N4O12	135403821	Major		Inter Info	[15], [16], [20], [44], [45]
D1502		St. John's Wort	NA	NA	Major		Inter Info	[15], [16], [20], [44], [45]
D1549		Temsirolimus	C56H87NO16	6918289	Major		Inter Info	[15], [18], [407]
D0106		Armodafinil	C15H15NO2S	9690109	Moderate		Inter Info	[252], [15], [16], [17], [82], [44], [512]
D0300		Cenobamate	C10H10ClN5O2	11962412	Moderate		Inter Info	[252], [15], [16], [17], [82], [44], [512]
D0545		Echinacea	NA	NA	Moderate		Inter Info	[15], [543]
D0601		Eslicarbazepine	C15H14N2O2	9881504	Moderate		Inter Info	[252], [15], [16], [17], [82], [44], [512]
D1493		Somapacitan	C54H95N13O20S2	129894493	Moderate		Inter Info	[16], [82], [44]
D1495		Somatrem	C43H72N14O14	5487805	Moderate		Inter Info	[252], [15], [16], [17], [82], [44], [512]
D1081		Modafinil	C15H15NO2S	4236	Moderate		Inter Info	[252], [15], [16], [17], [82], [44], [512]
D1099		Nafcillin	C21H22N2O5S	8982	Moderate		Inter Info	[252], [15], [16], [17], [82], [44], [512]
D1186		Oritavancin	C86H97Cl3N10O26	16136912	Moderate		Inter Info	[252], [15], [16], [17], [82], [44], [512]
D1198		Oxcarbazepine	C15H12N2O2	34312	Moderate		Inter Info	[252], [15], [16], [17], [82], [44], [512]
D1433		Rufinamide	C10H8F2N4O	129228	Moderate		Inter Info	[252], [15], [16], [17], [82], [44], [512]
D1494		Somatotropin	NA	NA	Moderate		Inter Info	[16], [82], [44]
D1518		Sulfinpyrazone	C23H20N2O3S	5342	Moderate		Inter Info	[252], [15], [16], [17], [82], [44], [512]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1673		Valbenazine	C24H38N2O4	24795069	Major		Inter Info	[163]

References
1	Bartkowski RR, Goldberg ME, Larijani GE, Boerner T "Inhibition of alfentanil metabolism by erythromycin." Clin Pharmacol Ther 46 (1989): 99-102. [PMID: 2501060]
2	Bartkowski RR, McDonnell TE "Prolonged alfentanil effect following erythromycin administration." Anesthesiology 73 (1990): 566-8. [PMID: 2203286]
3	Kharasch ED, Thummel KE "Human alfentanil metabolism by cytochrome P450 3A3/4. An explanation for the interindividual variability in alfentanil clearance?" Anesth Analg 76 (1993): 1033-9. [PMID: 8484504]
4	Kharasch ED, Walker A, Hoffer C, Sheffels P "Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis." Clin Pharmacol Ther 76 (2004): 452-66. [PMID: 15536460]
5	Klees TM, Sheffels P, Dale O, Kharasch ED "Metabolism of alfentanil by cytochrome P4503A enzymes." Drug Metab Dispos 33 (2005): 303-11. [PMID: 15557344]
6	Klees TM, Sheffels P, Thummel KE, Kharasch ED "Pharmacogenetic Determinants of Human Liver Microsomal Alfentanil Metabolism and the Role of Cytochrome P450 3A5." Anesthesiology 102 (2005): 550-556. [PMID: 15731592]
7	Koehntop DE, Noormohamed SE, Fletcher CV "Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation." Pharmacotherapy 14 (1994): 592-9. [PMID: 7997393]
8	Labroo RB, Thummel KE, Kunze KL, Podoll T, Trager WF, Kharasch ED "Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism." Drug Metab Dispos 23 (1995): 490-6. [PMID: 7600917]
9	Palkama VJ, Isohanni MH, Neuvonen PJ, Olkkola KT "The effect of intravenous and oral fluconazole on the pharmacokinetics and pharmacodynamics of intravenous alfentanil." Anesth Analg 87 (1998): 190-4. [PMID: 9661572]
10	Product Information. Alfenta (alfentanil). Janssen Pharmaceutica, Titusville, NJ.
11	Yate PM, Thomas D, Short SM, Sebel PS, Morton J "Comparison of infusions of alfentanil or pethidine for sedation of ventilated patients on the ITU." Br J Anaesth 58 (1986): 1091-9. [PMID: 2876719]
12	Yun CH, Wood M, Wood AJ, Guengerich FP "Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4: an explanation of the variable elimination clearance." Anesthesiology 77 (1992): 467-74. [PMID: 1519785]
13	Ibrahim AE, Feldman J, Karim A, Kharasch ED "Simultaneous Assessment of Drug Interactions with Low- and High-Extraction Opioids: Application to Parecoxib Effects on the Pharmacokinetics and Pharmacodynamics of Fentanyl and Alfentanil." Anesthesiology 98 (2003): 853-861. [PMID: 12657846]
14	Kharasch ED, Russell M, Mautz D, Thummel KE, Kunze KL, Bowdle A, Cox K "The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions." Anesthesiology 87 (1997): 36-50. [PMID: 9232132]
15	Cerner Multum, Inc. "Australian Product Information.".
16	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
17	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
18	Product Information. Sporanox (itraconazole). Janssen Pharmaceutica, Titusville, NJ.
19	Product Information. Uroxatral (alfuzosin). sanofi-aventis , Bridgewater, NJ.
20	Product Information. Stribild (cobicistat/elvitegravir/emtricitabine/tenofov). Gilead Sciences, Foster City, CA.
21	Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
22	Product Information. Coartem (artemether-lumefantrine). Novartis Pharmaceuticals, East Hanover, NJ.
23	Product Information. Stendra (avanafil). Vivus Inc, Mountain View, CA.
24	Product Information. Inlyta (axitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
25	Product Information. Evotaz (atazanavir-cobicistat). Bristol-Myers Squibb, Princeton, NJ.
26	Product Information. Tracleer (bosentan). Acetelion Pharmaceuticals US, Inc, South San Francisco, CA.
27	Product Information. Bosulif (bosutinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
28	Bolland MJ, Bagg W, Thomas MG, Lucas JA, Ticehurst R, Black PN "Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole." Ann Pharmacother 38 (2004): 46-9. [PMID: 14742792]
29	Daveluy A, Raignoux C, Miremont-Salame G, et al. "Drug interactions between inhaled corticosteroids and enzymatic inhibitors." Eur J Clin Pharmacol (2009):. [PMID: 19399485]
30	De Wachter E, Malfroot A, De Schutter I, Vanbesien J, De Schepper J "Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450." J Calif Dent Assoc 2 (2003): 72-5. [PMID: 15463853]
31	De Wachter E, Vanbesien J, De Schutter I, Malfroot A, De Schepper J "Rapidly developing Cushing syndrome in a 4-year-old patient during combined treatment with itraconazole and inhaled budesonide." Eur J Pediatr (2003):. [PMID: 12719971]
32	Edsbacker S, Andersson T "Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease." Clin Pharmacokinet 43 (2004): 803-21. [PMID: 15355126]
33	Jonsson G, Astrom A, Andersson P "Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver." Drug Metab Dispos 23 (1995): 137-42. [PMID: 7720517]
34	Kedem E, Shahar E, Hassoun G, Pollack S "Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient." J Asthma 47 (2010): 830-1. [PMID: 20653496]
35	Main KM, Skov M, Sillesen IB, et al. "Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient." Acta Paediatr 91 (2002): 1008-11. [PMID: 12412882]
36	Molimard M, Girodet PO, Pollet C, et al. "Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation." Drug Saf 31 (2008): 769-74. [PMID: 18707191]
37	Product Information. Entocort (budesonide). AstraZeneca Pharma Inc, Mississauga, ON.
38	Product Information. Incivek (telaprevir). Vertex Pharmaceuticals, Cambridge, MA.
39	Product Information. Victrelis (boceprevir). Schering-Plough Corporation, Kenilworth, NJ.
40	Raaska K, Niemi M, Neuvonen M, Neuvonen PJ, Kivisto KT "Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole." Clin Pharmacol Ther 72 (2002): 362-369. [PMID: 12386638]
41	Skov M, Main KM, Sillesen IB, Muller J, Koch C, Lanng S "Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide." Eur Respir J 20 (2002): 127-33. [PMID: 12166560]
42	Product Information. Butorphanol Tartrate (butorphanol). Apotex Corporation, Weston, FL.
43	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
44	Product Information. Tybost (cobicistat). Gilead Sciences, Foster City, CA.
45	Product Information. Vitekta (elvitegravir). Gilead Sciences, Foster City, CA.
46	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
47	Product Information. Pletal (cilostazol). Otsuka American Pharmaceuticals, Rockville, MD.
48	Suri A, Bramer SL "Effect of omeprazole on the metabolism of cilostazol." Clin Pharmacokinet 37 (1999): 53-9. [PMID: 10702887]
49	Suri A, Forbes WP, Bramer SL "Effects of CYP3A inhibition on the metabolism of cilostazol." Clin Pharmacokinet 37 (1999): 61-8. [PMID: 10702888]
50	Bran S, Murray WA, Hirsch IB, Palmer JP "Long QT syndrome during high-dose cisapride." Arch Intern Med 155 (1995): 765-8. [PMID: 7695465]
51	Caley CF "Cisapride interaction with antidepressants." Ann Pharmacother 30 (1996): 684. [PMID: 8792962]
52	Desta Z, Soukhova N, Mahal SK, Flockhart DA "Interaction of cisapride with the human cytochrome P450 system: metabolism and inhibition studies." Drug Metab Dispos 28 (2000): 789-800. [PMID: 10859153]
53	Dresser GK, Spence JD, Bailey DG "Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition." Clin Pharmacokinet 38 (2000): 41-57. [PMID: 10668858]
54	Gray VS "Syncopal episodes associated with cisapride and concurrent drugs." Ann Pharmacother 32 (1998): 648-51. [PMID: 9640482]
55	Hill SL, Evangelista JK, Pizzi AM, Mobassaleh M, Fulton DR, Berul CI "Proarrhythmia associated with cisapride in children." Pediatrics 101 (1998): 1053-6. [PMID: 9606235]
56	Lewin MB, Bryant RM, Fenrich AL, Grifka RG "Cisapride-induced long QT interval." J Pediatr 128 (1996): 279-81. [PMID: 8636830]
57	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
58	Nemeroff CB, Devane CL, Pollock BG "Newer antidepressants and the cytochrome p450 system." Am J Psychiatry 153 (1996): 311-20. [PMID: 8610817]
59	Product Information. Propulsid (cisapride). Janssen Pharmaceutica, Titusville, NJ.
60	Product Information. Serzone (nefazodone). Bristol-Myers Squibb, Princeton, NJ.
61	Riesenman C "Antidepressant drug interactions and the cytochrome p450 system: a critical appraisal." Pharmacotherapy 15 (1995): s84-99. [PMID: 8587855]
62	Vitola J, Vukanovic J, Roden DM "Cisapride-induced torsades de pointes." J Cardiovasc Electrophysiol 9 (1998): 1109-13. [PMID: 9817562]
63	Itkonen MK, Tornio A, Lapatto-Reiniluoto O, et al. "Clopidogrel increases dasabuvir exposure with or without ritonavir, and ritonavir inhibits the bioactivation of clopidogrel." Clin Pharmacol Ther 105 (2019): 219-28. [PMID: 29696643]
64	Lau WC, Gurbel PA "Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome P450 3A4." Pharm Res 23 (2006): 2691-708. [PMID: 17061171]
65	Lau WC, Gurbel PA, Watkins PB, et al. "Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel Resistance." Circulation 109 (2004): 166-71. [PMID: 14707025]
66	Marsousi N, Daali Y, Fontana P, et.al "Impact of boosted antiretroviral therapy on the pharmacokinetics and efficacy of clopidogrel and prasugrel active metabolites." Clin Pharmacokinet 57 (2018): 1347-54. [PMID: 29453687]
67	Metzger NL, Momary KM "A patient with HIV and tuberculosis with diminished clopidogrel response." Int J STD AIDS (2013):. [PMID: 24352136]
68	Suh JW, Koo BK, Zhang SY, et al. "Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel." CMAJ 174 (2006): 1715-22. [PMID: 16754899]
69	Product Information. Verzenio (abemaciclib). Lilly, Eli and Company, Indianapolis, IN.
70	Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
71	Hutchinson MR, Menelaou A, Foster DJ, Coller JK, Somogyi AA "CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes." Br J Clin Pharmacol 57 (2004): 287-97. [PMID: 14998425]
72	Product Information. Zohydro ER (HYDROcodone). Zogenix, Inc, San Diego, CA.
73	Vizcaychipi MP, Walker S, Palazzo M "Serotonin syndrome triggered by tramadol." Br J Anaesth 99 (2007): 919. [PMID: 18006535]
74	Product Information. Orladeyo (berotralstat). BioCryst Pharmaceuticals Inc, Durham, NC.
75	Product Information. Rexulti (brexpiprazole). Otsuka American Pharmaceuticals Inc, Rockville, MD.
76	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
77	Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
78	Product Information. Aliqopa (copanlisib). Bayer Pharmaceutical Inc, West Haven, CT.
79	Product Information. Daklinza (daclatasvir). Bristol-Myers Squibb, Princeton, NJ.
80	Product Information. Emflaza (deflazacort). Marathon Pharmaceuticals, Deerfield, IL.
81	Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
82	Product Information. Genvoya (cobicistat/elvitegravir/emtricitabine/tenofov). Gilead Sciences, Foster City, CA.
83	Product Information. Symtuza (cobicistat/darunavir/emtricitabine/tenof). Janssen Pharmaceuticals, Titusville, NJ.
84	Product Information. Orilissa (elagolix). AbbVie US LLC, North Chicago, IL.
85	Davenport JM, Covington P, Bonifacio L, McIntyre G, Venitz J "Effect of uptake transporters OAT3 and OATPIBI and efflux transporter MRP2 on the pharmacokinetics of eluxadoline." J Clin Pharmacol 55 (2015): 534-42. [PMID: 25491493]
86	Product Information. Viberzi (eluxadoline). Actavis Pharma, Inc., Parsippany, NJ.
87	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
88	Han TH, Gopal AK, Ramchandren R, et al. "CYP3A-mediated drug-drug interaction potential and excretion of brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive hematologic malignancies." J Clin Pharmacol 53 (2013): 866-77. [PMID: 23754575]
89	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
90	Product Information. Padcev (enfortumab vedotin). Seattle Genetics Inc, Bothell, WA.
91	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
92	Product Information. Balversa (erdafitinib). Janssen Products, LP, Horsham, PA.
93	Product Information. Inrebic (fedratinib). Celgene Corporation, Summit, NJ.
94	Arrington-Sanders R, Hutton N, Siberry GK "Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents." Pediatr Infect Dis J 25 (2006): 1044-1048. [PMID: 17072128]
95	Bhumbra NA, Sahloff EG, Oehrtman SJ, Horner JM "Exogenous Cushing syndrome with inhaled fluticasone in a child receiving lopinavir/ritonavir." Ann Pharmacother 41 (2007): 1306-9. [PMID: 17535841]
96	Boorsma M, Andersson N, Larsson P, Ullman A "Assessment of the relative systemic potency of inihaled fluticasone and budesonide." Eur Respir J 9 (1996): 1427-32. [PMID: 8836654]
97	Brus R "Effects of high-dose inhaled corticosteroids on plasma cortisol consentrations in healthy adults." Arch Intern Med 159 (1999): 1903-8. [PMID: 10493320]
98	Fardon TC, Lee DK, Haggart K, McFarlane LC, Lipworth BJ "Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate." Am J Respir Crit Care Med 170 (2004): 960-6. [PMID: 15184207]
99	Foisy MM, Yakiwchuk EM, Chiu I, Singh AE "Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature." HIV Med 9 (2008): 389-96. [PMID: 18459946]
100	Gillett MJ, Cameron PU, Nguyen HV, Hurley DM, Mallal SA "Iatrogenic Cushing's syndrome in an HIV-infected patient treated with ritonavir and inhaled fluticasone." AIDS 19 (2005): 740-1. [PMID: 15821405]
101	Grahnen A, Eckernas SA, Brundin RM, Ling-Andersson A "An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers." Br J Clin Pharmacol 38 (1994): 521-5. [PMID: 7888290]
102	Gupta SK, Dube MP "Exogenous Cushing syndrome mimicking human immunodeficiency virus lipodystrophy." Clin Infect Dis 35 (2002): E69-71. [PMID: 12203188]
103	Hillebrand-Haverkort ME, Prummel MF, ten Veen JH "Ritonavir-induced Cushing's syndrome in a patient treated with nasal fluticasone." AIDS 13 (1999): 1803. [PMID: 10509596]
104	Jinno S, Goshima C "Progression of Kaposi sarcoma associated with iatrogenic Cushing syndrome in a person with HIV/AIDS." AIDS Read 18 (2008): 100-4. [PMID: 18333287]
105	Johnson SR, Marion AA, Vrchoticky T, Emmanuel PJ, Lujan-Zilbermann J "Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone." J Pediatr 148 (2006): 386-388. [PMID: 16615973]
106	Kelly HW "Comparison of inhaled corticosteroids." Ann Pharmacother 32 (1998): 220-32. [PMID: 9496409]
107	Li AM "Ritonavir and fluticasone: Beware of this potentially fatal combination." J Pediatr 148 (2006): 294-5. [PMID: 16615953]
108	Lipworth BJ "Systemic adverse effects of inhaled corticosteroid therapy - A systematic review and meta-analysis." Arch Intern Med 159 (1999): 941-55. [PMID: 10326936]
109	Naef R, Schmid C, Hofer M, Minder S, Speich R, Boehler A "Itraconazole comedication increases systemic levels of inhaled fluticasone in lung transplant recipients." Respiration 74 (2007): 418-22. [PMID: 17003527]
110	Nocent C, Raherison C, Dupon M, Taytard A "Unexpected effects of inhaled fluticasone in an HIV patient with asthma." J Asthma 41 (2004): 793-5. [PMID: 15641628]
111	Parmar JS, Howell T, Kelly J, Bilton D "Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis." Thorax 57 (2002): 749-50. [PMID: 12149540]
112	Pearce RE, Leeder JS, Kearns GL "Biotransformation of fluticasone: in vitro characterization." Drug Metab Dispos 34 (2006): 1035-40. [PMID: 16565171]
113	Pessanha TM, Campos JM, Barros AC, Pone MV, Garrido JR, Pone SM "Iatrogenic Cushing's syndrome in a adolescent with AIDSs on ritonavir and inhaled fluticasone. case report and literature review." AIDS 21 (2007): 529-32. [PMID: 17301576]
114	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
115	Product Information. Flonase (fluticasone). Glaxo Wellcome, Research Triangle Park, NC.
116	Product Information. Flovent (fluticasone). Glaxo Wellcome, Research Triangle Park, NC.
117	Product Information. Norvir (ritonavir). Abbott Pharmaceutical, Abbott Park, IL.
118	Product Information. Veramyst (fluticasone nasal). GlaxoSmithKline, Research Triangle Park, NC.
119	Rouanet I, Peyriere H, Mauboussin JM, Vincent D "Cushing's syndrome in a patient treated by ritonavir/lopinavir and inhaled fluticasone." HIV Med 4 (2003): 149-50. [PMID: 12702137]
120	Sastre J "Pharmacology of fluticasone propionate." J Investig Allergol Clin Immunol 7 (1997): 382-4. [PMID: 9416555]
121	Schmid C, Naef R, Speich R, Boehler A "Addition of inhaled fluticasone propionate to systemic immunosuppression after lung transplantation: Cushing's Syndrome in patients on itraconazole comedication." Transplantation 76 (2003): 263-4. [PMID: 12865822]
122	Soldatos G, Sztal-Mazer S, Woolley I, Stockigt J "Exogenous glucocorticoid excess as a result of ritonavir-fluticasone interaction." Intern Med J 35 (2005): 67-8. [PMID: 15667475]
123	Todd GR, Acerini CL, Ross-Russell, Zahra S, Warner JT, McCance D "Survey of adrenal crisis associated witwh inhaled corticosteroids in the United Kingdom." Arch Dis Child 87 (2002): 457-61. [PMID: 12456538]
124	Vassiliadi D, Tsagarakis S "Unusual causes of Cushing's syndrome." Arq Bras Endocrinol Metabol 51 (2007): 1245-52. [PMID: 18209862]
125	Woods DR, Arun CS, Corris PA, Perros P "Cushing's syndrome without excess cortisol." BMJ 332 (2006): 469-70. [PMID: 16497762]
126	Bernecker C, West TB, Mansmann G, Scherbaum WA, Willenberg HS "Hypercortisolism caused by ritonavir associated inhibition of CYP 3A4 under inhalative glucocorticoid therapy. 2 case reports and a review of the literature." Exp Clin Endocrinol Diabetes 120 (2012): 125-7. [PMID: 22328106]
127	Kempsford R, Norris V, Siederer S "Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD." Pulm Pharmacol Ther 26 (2013): 256-64. [PMID: 23232038]
128	Lonnebo A, Grahnen A, Jansson B, Brundin RM, Lingandersson A, Eckernas SA "An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers." Eur J Clin Pharmacol 49 (1996): 459-63. [PMID: 8706770]
129	Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA "Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in HIV-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases." J Clin Endocrinol Metab 90 (2005): 4394-8. [PMID: 15755851]
130	Valin N, De Castro N, Garrait V, Bergeron A, Bouche C, Molina JM "Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature." J Int Assoc Physicians AIDS Care 8 (2009): 113-21. [PMID: 19270151]
131	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
132	Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
133	Product Information. Zepatier (elbasvir-grazoprevir). Merck &amp Company Inc, Whitehouse Station, NJ.
134	Product Information. Nourianz (istradefylline). Kyowa Kirin, Inc, Bedminster, NJ.
135	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
136	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
137	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
138	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
139	Product Information. Dayvigo (lemborexant). Eisai Inc, Woodcliff Lake, NJ.
140	Product Information. Lorbrena (lorlatinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
141	Product Information. Zepzelca (lurbinectedin). Jazz Pharmaceuticals, Palo Alto, CA.
142	Abbas R, Hug BA, Leister C, Burns J, Sonnichsen D "Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects." Br J Clin Pharmacol 71 (2011): 522-7. [PMID: 21395644]
143	Product Information. Nerlynx (neratinib). Puma Biotechnology, Inc., Los Angeles, CA.
144	Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
145	Product Information. Olinvyk (oliceridine). Trevena Inc, Chesterbrook, PA.
146	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
147	Product Information. Isturisa (osilodrostat). Recordati Rare Diseases Inc, Lebanon, NJ.
148	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
149	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
150	Product Information. Ibrance (palbociclib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
151	Product Information. Pemazyre (pemigatinib). Incyte Corporation, Wilmington, DE.
152	Product Information. Polivy (polatuzumab vedotin). Genentech, South San Francisco, CA.
153	Product Information. Gavreto (pralsetinib). Blueprint Medicines Corporation, Cambridge, MA.
154	Product Information. Orgovyx (relugolix). Myovant Sciences, Inc., Brisbane, CA.
155	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
156	Product Information. Qinlock (ripretinib). Deciphera Pharmaceuticals, Waltham, MA.
157	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
158	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
159	Product Information. Odomzo (sonidegib). Novartis Pharmaceuticals, East Hanover, NJ.
160	Product Information. Tazverik (tazemetostat). Epizyme, Inc, Cambridge, MA.
161	Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
162	Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
163	Product Information. Ingrezza (valbenazine). Neurocrine Biosciences, Inc., San Diego, CA.
164	Product Information. Venclexta (venetoclax). AbbVie US LLC, North Chicago, IL.
165	Product Information. Oxbryta (voxelotor). Global Blood Therapeutics, Inc., South San Francisco, CA.
166	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
167	Product Information. Cotellic (cobimetinib). Genentech, South San Francisco, CA.
168	Akdag I, Ersoy A, Kahvecioglu S, Gullulu M, Dilek K "Acute colchicine intoxication during clarithromycin administration in patients with chronic renal failure." J Nephrol 19 (2006): 515-7. [PMID: 17048210]
169	Boomershine KH "Colchicine-induced rhabdomyolysis." Ann Pharmacother 36 (2002): 824-6. [PMID: 11978160]
170	Caraco Y, Putterman C, Rahamimov R, Ben-Chetrit E "Acute colchicine intoxication: possible role of erythromycin administration." J Rheumatol 19 (1992): 494-6. [PMID: 1578471]
171	Cheng VC, Ho PL, Yuen KY "Two probable cases of serious drug interaction between clarithromycin and colchicine." South Med J 98 (2005): 811-3. [PMID: 16144178]
172	Cohen O, Locketz G, Hershko AY, Gorshtein A, Levy Y "Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori." Rheumatol Int (2015):. [PMID: 26210999]
173	Colchicine: serious interactions. Prescrire Int 17 (2008): 151-3. [PMID: 19492485]
174	Dogukan A, Oymak FS, Taskapan H, Guven M, Tokgoz B, Utas C "Acute fatal colchicine intoxication in a patient on continuous ambulatory peritoneal dialysis (CAPD). Possible role of clarithromycin administration." Clin Nephrol 55 (2001): 181-2. [PMID: 11269688]
175	Hung IF, Wu AK, Cheng VC, et al. "Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study." Clin Infect Dis 41 (2005): 291-300. [PMID: 16007523]
176	McKinnell J, Tayek JA "Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis." J Clin Rheumatol 15 (2009): 303-5. [PMID: 19734738]
177	Product Information. Biaxin (clarithromycin). Abbott Pharmaceutical, Abbott Park, IL.
178	Product Information. Colcrys (colchicine). AR Scientific Inc, Philadelphia, PA.
179	Putterman C, Ben-Chetrit E, Caraco Y, Levy M "Colchicine intoxication: clinical pharmacology, risk factors, features, and management." Semin Arthritis Rheum 21 (1991): 143-55. [PMID: 1788551]
180	Rollot F, Pajot O, Chauvelot-Moachon L, Nazal EM, Kelaidi C, Blanche P "Acute colchicine intoxication during clarithromycin administration." Ann Pharmacother 38 (2004): 2074-7. [PMID: 15494379]
181	Schiff D, Drislane FW "Rapid-onset colchicine myoneuropathy." Arthritis Rheum 35 (1992): 1535-6. [PMID: 1472131]
182	Severe colchicine-macrolide interactions. Prescrire Int 12 (2003): 18-9. [PMID: 12602385]
183	Tateishi T, Soucek P, Caraco Y, Guengerich FP, Wood AJ "Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation." Biochem Pharmacol 53 (1996): 111-6. [PMID: 8960070]
184	van der Velden W, Huussen J, Ter Laak H, de Sevaux R "Colchicine-induced neuromyopathy in a patient with chronic renal failure: the role of clarithromycin." Neth J Med 66 (2008): 204-6. [PMID: 18490798]
185	Wilbur K, Makowsky M "Colchicine myotoxicity: case reports and literature review." Pharmacotherapy 24 (2004): 1784-92. [PMID: 15585444]
186	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
187	Product Information. Rescriptor (delavirdine). Pharmacia and Upjohn, Kalamazoo, MI.
188	Niwa T, Shiraga T, Takagi A "Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, CYP3A4 activities in human liver microsomes." Biol Pharm Bull 28 (2005): 1805-8. [PMID: 16141567]
189	Product Information. Enablex (darifenacin). Novartis Pharmaceuticals, East Hanover, NJ.
190	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
191	Ausband SC, Goodman PE "An unusual case of clarithromycin associated ergotism." J Emerg Med 4 (2001): 411-3. [PMID: 11728770]
192	Bird PA, Sturgess AD "Clinical ergotism with severe bilateral upper limb ischaemia precipitated by an erythromycin - ergotamine drug interaction." Aust N Z J Med 30 (2000): 635-6. [PMID: 11108077]
193	Blanche P, Rigolet A, Gombert B, Ginsburg C, Salmon D, Sicard D "Ergotism related to a single dose of ergotamine tartrate in an AIDS patient treated with ritonavir." Postgrad Med J 75 (1999): 546-7. [PMID: 10616689]
194	Caballero-Granado FJ, Viciana P, Cordero E, Gomez-Vera MJ, del Nozal M, Lopez-Cortes LF "Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient." Antimicrob Agents Chemother 41 (1997): 1207. [PMID: 9145904]
195	Eadie MJ "Clinically significant drug interactions with agents specific for migraine attacks." Cns Drugs 15 (2001): 105-18. [PMID: 11460889]
196	Francis H, Tyndall A, Webb J "Severe vascular spasm due to erythromycin-ergotamine interaction." Clin Rheumatol 3 (1984): 243-6. [PMID: 6236021]
197	Hayton AC "Precipitation of acute ergotism by triacetyloleandomycin." N Z Med J 69 (1969): 42. [PMID: 5304704]
198	Horowitz RS, Dart RC, Gomez HF "Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction." Arch Intern Med 156 (1996): 456-8. [PMID: 8607732]
199	Leroy F, Asseman P, Pruvost P, Adnet P, Lacroix D, Thery C "Dihydroergotamine-erythromycin-induced ergotism." Ann Intern Med 109 (1988): 249. [PMID: 3389610]
200	Liaudet L "Severe ergotism associated with interaction between ritonavir and ergotamine." BMJ 318 (1999): 771. [PMID: 10082701]
201	Liaudet L, Buclin T, Jaccard C, Eckert P "Severe ergotism associated with interaction between ritonavir and ergotamine." Br Med J 318 (1999): 771. [PMID: 10082701]
202	Matthews NT, Havill JH "Ergotism with therapeutic doses of ergotamine tartrate." N Z Med J 89 (1979): 476-7. [PMID: 314074]
203	Montero A, Giovannoni AG, Tvrde PL "Leg ischemia in a patient receiving ritonavir and ergotamine." Ann Intern Med 130 (1999): 329. [PMID: 10068398]
204	Mortier E, Pouchet J, Vinceneux P, Lalande M "Ergotism related to interaction between nelfinavir and ergotamine." Am J Med 110 (2001): 594. [PMID: 11347624]
205	Product Information. Cafergot (caffeine-ergotamine). Novartis Pharmaceuticals, East Hanover, NJ.
206	Product Information. D.H.E. 45 (dihydroergotamine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
207	Product Information. Methergine (methylergonovine). Novartis Pharmaceuticals, East Hanover, NJ.
208	Product Information. Migranal (dihydroergotamine nasal). Novartis Pharmaceuticals, East Hanover, NJ.
209	Rosenthal E, Sala F, Chichmanian RM, Batt M, Cassuto JP "Ergotism related to concurrent administration of ergotamine tartrate and indinavir." JAMA 281 (1999): 987. [PMID: 10086430]
210	Spiegel M, Schmidauer C, Kampfl A, Sarcletti M, Poewe W "Cerebral ergotism under treatment with ergotamine and ritonavir." Neurology 57 (2001): 743-4. [PMID: 11524501]
211	Srisuma S, Lavonas EJ, Wananukul W "Ergotism and factitious hypotension associated with interaction of ergotamine with CYP3A4 inhibitors." Clin Toxicol (Phila) (2014): 1-4. [PMID: 24978905]
212	Tribble MA, Gregg CR, Margolis DM, Amirkhan R, Smith JW "Fatal ergotism induced by an HIV protease inhibitor." Headache 42 (2002): 694-5. [PMID: 12482227]
213	Vila A, Mykietiuk A, Bonvehi P, Temporiti E, Uruena A, Herrera F "Clinical ergotism induced by ritonavir." Scand J Infect Dis 33 (2001): 788-9. [PMID: 11728055]
214	Ghali R, De Lean J, Douville Y, Noel HP, Labbe R "Erythromycin-associated ergotamine intoxication: arteriographic and electrophysiologic analysis of a rare cause of severe ischemia of the lower extremities and associated ischemic neuropathy." Ann Vasc Surg 7 (1993): 291-6. [PMID: 8391300]
215	Aronson JK, Grahame-Smith DG "Clinical pharmacology: adverse drug interactions." Br Med J 282 (1981): 288-91. [PMID: 6779990]
216	Engels FK, Mathot RA, Loos WJ, van Schaik RH, Verweij J "Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel." Cancer Biol Ther 5 (2006): 833-9. [PMID: 16775418]
217	McInnes GT, Brodie MJ "Drug interactions that matter: a critical reappraisal." Drugs 36 (1988): 83-110. [PMID: 3063497]
218	Product Information. Taxotere (docetaxel). Rhone-Poulenc Rorer, Collegeville, PA.
219	Starr SP, Hammann F, Gotta V, et al. "Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity." Br J Clin Pharmacol 450 (2016): 22-27. [PMID: 27868228]
220	Vodovar D, Arnaout M, Mongardon N, et al. "Severe docetaxel overdose induced by pharmacokinetic interaction with dronedarone." J Clin Oncol 29 (2011): e694-5. [PMID: 21730272]
221	Yong WP, Wang LZ, Tham LS, et al. "A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers." Cancer Chemother Pharmacol 62 (2008): 243-51. [PMID: 17909805]
222	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
223	Product Information. Prezcobix (cobicistat-darunavir). Janssen Pharmaceuticals, Titusville, NJ.
224	Product Information. Slynd (drospirenone). Exeltis USA, Inc., Chatham, NJ.
225	Product Information. Yasmin (drospirenone-ethinyl estradiol) Berlex Laboratories, Richmond, CA.
226	Product Information. Relpax (eletriptan). Pfizer U.S. Pharmaceuticals, New York, NY.
227	Product Information. Cerdelga (eliglustat). Genzyme Corporation, Cambridge, MA.
228	Product Information. Inspra (eplerenone). Searle, Chicago, IL.
229	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
230	Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM "Oral erythromycin and the risk of sudden death from cardiac causes." N Engl J Med 351 (2004): 1089-96. [PMID: 15356306]
231	Alderman CP, Gebauer MG, Gilbert AL, Condon JT "Possible interaction of zopiclone and nefazodone." Ann Pharmacother 35 (2001): 1378-80. [PMID: 11724087]
232	Becquemont L, Mouajjah S, Escaffre O, Beaune P, Funck-Bretano C, Jaillon P "Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism." Drug Metab Dispos 27 (1999): 1068-73. [PMID: 10460808]
233	Product Information. Imovane (zopiclone). Rhone-Poulenc Rorer Canada Inc, Laval, IN.
234	Product Information. Lunesta (eszopiclone). Sepracor Inc, Marlborough, MA.
235	Homma S, Takahashi KI, Nihei S, Kato F, Sugihara S, Nunoda S "The successful management of respiratory complications with long-term, low-dose macrolide administration in pediatric heart transplant recipients." Int Heart J (2014):. [PMID: 25297501]
236	Product Information. Afinitor (everolimus). Novartis Pharmaceuticals, East Hanover, NJ.
237	Labroo RB, Paine MF, Thummel KE, Kharasch ED "Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implicaitons for interindividual variability in disposition, efficacy, and drug interactions." Drug Metab Dispos 25 (1997): 1072-80. [PMID: 9311623]
238	Product Information. Actiq (fentanyl). Abbott Pharmaceutical, Abbott Park, IL.
239	Product Information. Duragesic Transdermal System (fentanyl). Janssen Pharmaceutica, Titusville, NJ.
240	Tateishi T, Krivoruk Y, Ueng YF, Wood AJ, Guengerich FP, Wood M "Identification of human cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation." Anesth Analg 82 (1996): 167-72. [PMID: 8712396]
241	Product Information. Sporonox (itraconazole). Janssen Pharmaceutica, Titusville, NJ.
242	Product Information. Toviaz (fesoterodine). Pfizer U.S. Pharmaceuticals Group, New York, NY.
243	Product Information. Addyi (flibanserin). Sprout Pharmaceuticals, Raleigh, NC.
244	Product Information. Intuniv (guanfacine). Shire US Inc, Florence, KY.
245	Abernethy DR, Wesche DL, Barbey JT, et al. "Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation." Br J Clin Pharmacol 51 (2001): 231-7. [PMID: 11298069]
246	Baune B, Flinois JP, Furlan V, et al. "Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5." J Pharm Pharmacol 51 (1999): 419-26. [PMID: 10385214]
247	Charbit B, Becquemont L, Lepere B, Peytavin G, Funck-Bretano C "Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrine." Clin Pharmacol Ther 72 (2002): 514-23. [PMID: 12426515]
248	Giao PT, de Vries PJ "Pharmacokinetic interactions of antimalarial agents." Clin Pharmacokinet 40 (2001): 343-73. [PMID: 11432537]
249	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
250	Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
251	Product Information. Fanapt (iloperidone). Vanda Pharmaceuticals Inc, Rockville, MD.
252	Canadian Pharmacists Association.
253	Corona G, Vaccher E, Sandron S, et al. "Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma." Clin Pharmacol Ther 83 (2008): 601-6. [PMID: 17713471]
254	Phansalker S, Desai AA, Bell D, et al "High-priority drug-drug interactions for use in electronic health records." J Am Med Inform Assoc 19 (2012): 735-43. [PMID: 22539083]
255	Product Information. Camptosar (irinotecan). Pharmacia and Upjohn, Kalamazoo, MI.
256	Product Information. Onivyde (irinotecan liposomal). Merrimack Pharmaceuticals, Cambridge, MA.
257	Product Information. Cresemba (isavuconazonium). Astellas Pharma US, Inc, Deerfield, IL.
258	Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
259	Product Information. Orkambi (ivacaftor-lumacaftor). Vertex Pharmaceuticals, Cambridge, MA.
260	Product Information. Symdeko 4-Week (ivacaftor-tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
261	Product Information. Trikafta (elexacaftor/ivacaftor/tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
262	Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
263	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
264	Product Information. Zokinvy (lonafarnib). Eiger BioPharmaceuticals, Palo Alto, CA.
265	Product Information. Fetzima (levomilnacipran). Forest Pharmaceuticals, St. Louis, MO.
266	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
267	Alderman CP "Possible interaction between nefazodone and pravastatin." Ann Pharmacother 33 (1999): 871. [PMID: 10466919]
268	Alderman CP "Possible interaction between nefazodone and pravastatin." Ann Pharmacother 34 (2000): 538-9. [PMID: 10466919]
269	Ayanian JZ, Fuchs CS, Stone RM "Lovastatin and rhabdomyolysis." Ann Intern Med 109 (1988): 682-3. [PMID: 3421582]
270	Bottorf MB "Possible interaction between nefazodone and pravastatin." Ann Pharmacother 34 (2000): 538. [PMID: 10772447]
271	Cheng CH, Miller C, Lowe C, Pearson VE "Rhabdomyolysis due to probable interaction between simvastatin and ritonavir." Am J Health Syst Pharm 59 (2002): 728-30. [PMID: 11977859]
272	Chouhan UM, Chakrabarti S, Millward LJ "Simvastatin interaction with clarithromycin and amiodarone causing myositis." Ann Pharmacother 39 (2005): 1760-1. [PMID: 16159992]
273	Corpier CL, Jones PH, Suki WN, et al. "Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients." JAMA 260 (1988): 239-41. [PMID: 3290520]
274	Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, Bernini F "New insights into the pharmacodynamic and pharmacokinetic properties of statins." Pharmacol Ther 84 (1999): 413-28. [PMID: 10665838]
275	East C, Alivizatos PA, Grundy SM, Jones PH, Farmer JA "Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation." N Engl J Med 318 (1988): 47-8. [PMID: 3275892]
276	Fichtenbaum CJ, Gerber JG, Rosenkranz SL, et al. "Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047." AIDS 16 (2002): 569-577. [PMID: 11873000]
277	Garnett WR "Interactions with hydroxymethylglutaryl-coenzyme A reductase inhibitors." Am J Health Syst Pharm 52 (1995): 1639-45. [PMID: 7583826]
278	Gilad R, Lampl Y "Rhabdomyolysis induced by simvastatin and ketoconazole treatment." Clin Neuropharmacol 22 (1999): 295-7. [PMID: 10516882]
279	Gruer PJK, Vega JM, Mercuri MF, Dobrinska MR, Tobert JA "Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin." Am J Cardiol 84 (1999): 811-5. [PMID: 10513779]
280	Grunden JW, Fisher KA "Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin." Ann Pharmacother 31 (1997): 859-63. [PMID: 9220046]
281	Hare CB, Vu MP, Grunfeld C, Lampiris HW "Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death." Clin Infect Dis 35 (2002): E111-2. [PMID: 12410494]
282	Horn M "Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals." Arch Dermatol 132 (1996): 1254. [PMID: 8859048]
283	Huynh T, Cordato D, Yang F, et al. "HMG coA reductase-inhibitor-related myopathy and the influence of drug interactions." Intern Med J 32(9-10) (2002): 486-90. [PMID: 12380704]
284	Itakura H, Vaughn D, Haller DG, O'Dwyer PJ "Rhabdomyolysis from cytochrome p-450 interaction of ketoconazole and simvastatin in prostate cancer." J Urol 169 (2003): 613. [PMID: 12544321]
285	Jacobson RH, Wang P, Glueck CJ "Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone." JAMA 277 (1997): 296. [PMID: 9002485]
286	Jacobson TA "Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors." Am J Cardiol 94 (2004): 1140-6. [PMID: 15518608]
287	Jody DN "Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone." JAMA 277 (1997): 296-7. [PMID: 9002485]
288	Kantola T, Kivisto KT, Neuvonen PJ "Effect of itraconazole on cerivastatin pharmacokinetics." Eur J Clin Pharmacol 54 (1999): 851-5. [PMID: 10027660]
289	Kantola T, Kivisto KT, Neuvonen PJ "Effect of itraconazole on the pharmacokinetics of atorvastatin." Clin Pharmacol Ther 64 (1998): 58-65. [PMID: 9695720]
290	Karnik NS, Maldonado JR "Antidepressant and statin interactions: a review and case report of simvastatin and nefazodone-induced rhabdomyolysis and transaminitis." Psychosomatics 46 (2005): 565-8. [PMID: 16288136]
291	Kivisto KT, Kantola T, Neuvonen PJ "Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin." Br J Clin Pharmacol 46 (1998): 49-53. [PMID: 9690949]
292	Lee AJ, Maddix DS "Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin." Ann Pharmacother 35 (2001): 26-31. [PMID: 11197581]
293	Lees RS, Lees AM "Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole." N Engl J Med 333 (1995): 664-5. [PMID: 7637734]
294	Neuvonen PJ, Backman JT, Niemi M "Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin." Clin Pharmacokinet 47 (2008): 463-74. [PMID: 18563955]
295	Neuvonen PJ, Jalava KM "Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid." Clin Pharmacol Ther 60 (1996): 54-61. [PMID: 8689812]
296	Neuvonen PJ, Kantola T, Kivisto KT "Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole." Clin Pharmacol Ther 63 (1998): 332-41. [PMID: 9542477]
297	Omar MA, Wilson JP "FDA adverse event reports on statin-associated rhabdomyolysis." Ann Pharmacother 36 (2002): 288-95. [PMID: 11847951]
298	Paoletti R, Corsini A, Bellosta S "Pharmacological interactions of statins." Atheroscler Suppl 3 (2002): 35-40. [PMID: 12044584]
299	Piliero PJ "Interaction between ritonavir and statins." Am J Med 112 (2002): 510-1. [PMID: 11959074]
300	Product Information. Advicor (lovastatin-niacin). Kos Pharmaceuticals, Miami, FL.
301	Product Information. Mevacor (lovastatin). Merck & Co, Inc, West Point, PA.
302	Product Information. Zocor (simvastatin). Merck & Co, Inc, West Point, PA.
303	Schmidt GA, Hoehns JD, Purcell JL, Friedman RL, Elhawi Y "Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir." J Am Board Fam Med 20 (2007): 411-6. [PMID: 17615423]
304	Sipe BE, Jones RJ, Bokhart GH "Rhabdomyolysis Causing AV Blockade Due to Possible Atorvastatin, Esomeprazole, and Clarithromycin Interaction." Ann Pharmacother 37 (2003): 808-11. [PMID: 12773066]
305	Skrabal MZ, Stading JA, Monaghan MS "Rhabdomyolysis associated with simvastatin-nefazodone therapy." South Med J 96 (2003): 1034-5. [PMID: 14570351]
306	Spach DH, Bauwens JE, Clark CD, Burke WG "Rhabdomyolysis associated with lovastatin and erythromycin use." West J Med 154 (1991): 213-5. [PMID: 2006579]
307	Stein CA, Goel S, Ghavamian R "Hepatitis and rhabdomyolysis in a patient with hormone refractory prostate cancer on ketoconazole and concurrent lovastatin therapy." Invest New Drugs 25 (2007): 277-8. [PMID: 17216557]
308	Thompson M, Samuels S "Rhabdomyolysis with simvastatin and nefazodone." Am J Psychiatry 159 (2002): 1607. [PMID: 12202291]
309	Watkins JL, Atkinson BJ, Pagliaro LC "Rhabdomyolysis in a prostate cancer patient taking ketoconazole and simvastatin: case report and review of the literature." Ann Pharmacother 45 (2011): e9. [PMID: 21304039]
310	Williams D, Feely J "Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors." Clin Pharmacokinet 41 (2002): 343-70. [PMID: 12036392]
311	Wong PW, Dillard TA, Kroenke K "Multiple organ toxicity from addition of erythromycin to long-term lovastatin therapy." South Med J 91 (1998): 202-5. [PMID: 9496876]
312	Product Information. Caplyta (lumateperone). Intra-Cellular Therapies, Inc., New York, NY.
313	Product Information. Latuda (lurasidone). Sunovion Pharmaceuticals Inc, Marlborough, MA.
314	Product Information. Opsumit (macitentan). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
315	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
316	Glynn AM, Slaughter RL, Brass C, et al "Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion." Clin Pharmacol Ther 39 (1986): 654-9. [PMID: 3709030]
317	Kandrotas RJ, Slaughter RL, Brass C, Jusko WJ "Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol." Clin Pharmacol Ther 42 (1987): 465-70. [PMID: 3311551]
318	Kotlyar M, Brewer ER, Golding M, Carson SW "Nefazodone inhibits methylprednisolone disposition and enhances its adrenal-suppressant effect." J Clin Psychopharmacol 23 (2003): 652-6. [PMID: 14624194]
319	LaForce CF, Szefler SJ, Miller MF, Ebling W, Brenner M "Inhibition of methylprednisolone elimination in the presence of erythromycin therapy." J Allergy Clin Immunol 72 (1983): 34-9. [PMID: 6602160]
320	Varis T, Backman JT, Kivisto KT, Neuvonen PJ "Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone." Clin Pharmacol Ther 67 (2000): 215-21. [PMID: 10741623]
321	Varis T, Kaukonen KM, Kivisto KT, Neuvonen PJ "Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole." Clin Pharmacol Ther 64 (1998): 363-8. [PMID: 9797792]
322	Dutreix C, Munarini F, Lorenzo S, Roesel J, Wang Y "Investigation into CYP3A4-mediated drug-drug interactions on midostaurin in healthy volunteers." Cancer Chemother Pharmacol 72 (2013): 1223-34. [PMID: 24085261]
323	Product Information. Rydapt (midostaurin). Novartis Pharmaceuticals, East Hanover, NJ.
324	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
325	Product Information. Mifeprex (mifepristone) Danco Laboratories, New York, NY.
326	Product Information. Movantik (naloxegol). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
327	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
328	Product Information. Nimotop (nimodipine). Bayer, West Haven, CT.
329	Product Information. OxyContin (oxycodone). Purdue Frederick Company, Norwalk, CT.
330	Hamberg P, Woo MM, Chen LC, et al. "Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor." Cancer Chemother Pharmacol 68 (2011): 805-13. [PMID: 21706316]
331	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
332	Product Information. Votrient (pazopanib). GlaxoSmithKline, Research Triangle Park, NC.
333	Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
334	Product Information. Iclusig (ponatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
335	DeVane CL, Nemeroff CB "Clinical pharmacokinetics of quetiapine - An atypical antipsychotic." Clin Pharmacokinet 40 (2001): 509-22. [PMID: 11510628]
336	Geraci MJ, McCoy SL, Crum PM, Patel RA "Antipsychotic-induced priapism in an HIV patient: a cytochrome P450-mediated drug interaction." Int J Emerg Med 3 (2010): 81-4. [PMID: 20606815]
337	Grimm SW, Richtand NM, Winter HR, Stams KR, Reele SB "Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics." Br J Clin Pharmacol 61 (2006): 58-69. [PMID: 16390352]
338	Hantson P, Di Fazio V, Wallemacq P "Toxicokinetic interaction between quetiapine and antiretroviral therapy following quetiapine overdose." Drug Metab Lett 4 (2010): 7-8. [PMID: 20201782]
339	Product Information. Seroquel (quetiapine). Zeneca Pharmaceuticals, Wilmington, DE.
340	Spina E, de Leon J "Metabolic drug interactions with newer antipsychotics: a comparative review." Basic Clin Pharmacol Toxicol 100 (2007): 4-22. [PMID: 17214606]
341	Spina E, Scordo MG, D'Arrigo C "Metabolic drug interactions with new psychotropic agents." Fundam Clin Pharmacol 17 (2003): 517-38. [PMID: 14703714]
342	Urichuk L, Prior TI, Dursun S, Baker G "Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions." Curr Drug Metab 9 (2008): 410-8. [PMID: 18537577]
343	Schulz-Du Bois C, Schulz-Du Bois AC, Bewig B, et al. "Major increase of quetiapine steady-state plasma concentration following co-administration of clarithromycin: confirmation of the pharmacokinetic interaction potential of quetiapine." Pharmacopsychiatry 41 (2008): 258-9. [PMID: 19067264]
344	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
345	Product Information. Adempas (riociguat). Bayer Pharmaceutical Inc, West Haven, CT.
346	Product Information. Xarelto (rivaroxaban). Bayer Inc, Toronto, IA.
347	Product Information. Jakafi (ruxolitinib). Incyte Corporation, Wilmington, DE.
348	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
349	Hall MCS, Ahmad S "Interaction between sildenafil and HIV-1 combination therapy." Lancet 353 (1999): 2071-2. [PMID: 10376645]
350	Hyland R, Roe GH, Jones BC, Smith DA "Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil." Br J Clin Pharmaacol 51 (2001): 239-48. [PMID: 11298070]
351	Merry C, Barry MG, Ryan M, Tjia JF, Hennessy M, Eagling VA, Mulcahy F, Back DJ "Interaction of sildenafil and indinavir when co-administered to HIV-positive patients." AIDS 13 (1999): f101-7. [PMID: 10546851]
352	Muirhead GJ, Wulff MB, Fielding A, Kleinermans D, Buss N "Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir." Br J Clin Pharmacol 50 (2000): 99-107. [PMID: 10930961]
353	Nandwani R, Gourlay Y "Possible interaction between sildenafil and HIV combination therapy." Lancet 353 (1999): 840. [PMID: 10459981]
354	Product Information. Revatio (sildenafil). Pfizer U.S. Pharmaceuticals Group, New York, NY.
355	Product Information. Viagra (sildenafil). Pfizer US Pharmaceuticals, New York, NY.
356	Warrington JS, Shader RI, vonMoltke LL, Greenblatt DJ "In vitro biotransformation of sildenafil (Viagra): Identification of human cytochromes and potential drug interactions." Drug Metab Disposition 28 (2000): 392-7. [PMID: 10725306]
357	Product Information. Rapaflo (silodosin). Watson Pharmaceuticals, Corona, CA.
358	Product Information. Olysio (simeprevir). Janssen Pharmaceuticals, Titusville, NJ.
359	Claesson K, Brattstrom C, Burke JT "Sirolimus and erythromycin interaction: two cases." Transplant Proc 33 (2001): 2136. [PMID: 11377477]
360	Dodds-Ashley E "Management of drug and food interactions with azole antifungal agents in transplant recipients." Pharmacotherapy 30 (2010): 842-54. [PMID: 20653361]
361	Floren LC, Christians U, Zimmerman JJ, et al "Sirolimus oral bioavailability increases ten-fold with concomitant ketoconazole." Clin Pharmacol Ther 65 (1999): 159.
362	Product Information. Noxafil (posaconazole). Schering-Plough Corporation, Kenilworth, NJ.
363	Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
364	Product Information. VFEND (voriconazole). Pfizer U.S. Pharmaceuticals, New York, NY.
365	Product Information. VESIcare (solifenacin). GlaxoSmithKline, Research Triangle Park, NC.
366	Product Information. Belsomra (suvorexant). Merck & Company Inc, Whitehouse Station, NJ.
367	Albengres E, Le Louet H, Tillement JP "Systemic antifungal agents. Drug interactions of clinical significance." Drug Saf 18 (1998): 83-97. [PMID: 9512916]
368	Assan R, Fredj G, Larger E, Feutren G, Bismuth H "FK 506/fluconazole interaction enhances FK 506 nephrotoxicity." Diabete Metab 20 (1994): 49-52. [PMID: 7520007]
369	Barau C, Blouin P, Creput C, Taburet AM, Durrbach A, Furlan V "Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient." Fundam Clin Pharmacol 23 (2009): 423-5. [PMID: 19709321]
370	Billaud EM, Guillemain R, Tacco F, Chevalier P "Evidence for a pharmacokinetic interaction between itraconazole and tacrolimus in organ transplant patients." Br J Clin Pharmacol 46 (1998): 271-4. [PMID: 9764970]
371	Cakaloglu Y, Tredger JM, Devlin J, Williams R "Importance of cytochrome p-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients." Hepatology 20 (1994): 309-16. [PMID: 7519161]
372	Capone D, Gentile A, Imperatore P, Palmiero G, Basile V "Effects of itraconazole on tacrolimus blood concentrations in a renal transplant recipient." Ann Pharmacother 33 (1999): 1124-5. [PMID: 10534229]
373	Floren LC, Bekersky I, Benet LZ, et al. "Tacrolimus oral bioavailability doubles with coadministration of ketoconazole." Clin Pharmacol Ther 62 (1997): 41-9. [PMID: 9246018]
374	Furlan V, Perello L, Jacquemin E, Debray D, Taburet AM "Interactions between FK506 and rifampin or erythromycin in pediatric liver recipients." Transplantation 59 (1995): 1217-8. [PMID: 7537398]
375	Gomez G, Alvarez ML, Errasti P, Lavilla FJ, Garcia N, Ballester B, Garcia I, Purroy A "Acute tacrolimus nephrotoxicity in renal transplant patients treated with clarithromycin." Transplant Proc 31 (1999): 2250-1. [PMID: 10500563]
376	Ibrahim RB, Abella EM, Chandrasekar PH "Tacrolimus-clarithromycin interaction in a patient receiving bone marrow transplantation." Ann Pharmacother 36 (2002): 1971-1972. [PMID: 12452763]
377	Jain AB, Venkataramanan R, Eghtesad B, et al. "Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients." Liver Transpl 9 (2003): 954-60. [PMID: 12942457]
378	Jain AK, Venkataramanan R, Shapiro R, et al. "Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients." Transplant Proc 34 (2002): 1540-1. [PMID: 12176474]
379	Jain AK, Venkataramanan R, Shapiro R, et al. "The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients." Liver Transpl 8 (2002): 841-5. [PMID: 12200788]
380	Jensen C, Jordan M, Shapiro R, et al. "Interaction between tacrolimus and erythromycin." Lancet 344 (1994): 825. [PMID: 7521928]
381	Katari SR, Magnone M, Shapiro R, et al "Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients." Clin Transplant 11 (1997): 237-42. [PMID: 9193849]
382	Kunicki PK, Sobieszczanska-Malek M "Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient." Ther Drug Monit 27 (2005): 107-108. [PMID: 15665756]
383	Macias MO, Salvador P, Hurtado JL, Martin I "Tacrolimus-itraconazole interaction in a kidney transplant patient." Ann Pharmacother 34 (2000): 536. [PMID: 10772445]
384	Manez R, Martin M, Raman V, et al. "Fluconazole therapy in transplant recipients receiving FK506." Transplantation 57 (1994): 1521-3. [PMID: 7515201]
385	Mertz D, Battegay M, Marzolini C, Mayr M "Drug-Drug Interaction in a Kidney Transplant Recipient Receiving HIV Salvage Therapy and Tacrolimus." Am J Kidney Dis (2009):. [PMID: 19346040]
386	Mieles L, Venkataramanan R, Yokoyama I, Warty VJ, Starzl TE "Interaction between FK506 and clotrimazole in a liver transplant recipient." Transplantation 52 (1991): 1086-7. [PMID: 1721250]
387	Moreno M, Latorre A, Manzanares C, et al "Clinical management of tacrolimus drug interactions in renal transplant patients." Transplant Proc 31 (1999): 2252-3. [PMID: 10500564]
388	Olyaei AJ, deMattos AM, Norman DJ, Bennett WM "Interaction between tacrolimus and nefazodone in a stable renal transplant recipient." Pharmacotherapy 18 (1998): 1356-9. [PMID: 9855339]
389	Osowski CL, Dix SP, Lin LS, Mullins RE, Geller RB, Wingard JR "Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients." Transplantation 61 (1996): 1268-72. [PMID: 8610430]
390	Pai MP, Allen S "Voriconazole inhibition of tacrolimus metabolism." Clin Infect Dis 36 (2003): 1089-91. [PMID: 12684931]
391	Parissis H, Gould K, Dark J "Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation." J Cardiothorac Surg 5 (2010): 70. [PMID: 20813025]
392	Pea F, Furlanut M "Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions." Clin Pharmacokinet 40 (2001): 833-868. [PMID: 11735605]
393	Pea F, Tavio M, Pavan F, et al. "Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients." Antivir Ther 13 (2008): 739-42. [PMID: 18771060]
394	Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
395	Schonder KS, Shullo MA, Okusanya O "Tacrolimus and lopinavir/ritonavir interaction in liver transplantation." Ann Pharmacother 37 (2003): 1793-6. [PMID: 14632538]
396	Shaeffer MS, Collier D, Sorrell MF "Interaction between FK506 and erythromycin." Ann Pharmacother 28 (1994): 280-1. [PMID: 7513563]
397	Soltero L, Carbajal H, Rodriguez-Montalvo C, Valdes A "Coadministration of tacrolimus and ketoconazole in renal transplant recipients: cost analysis and review of metabolic effects." Transplant Proc 35 (2003): 1319-21. [PMID: 12826147]
398	Tsapepas DS, Webber AB, Aull MJ, Figueiro JM, Saal SD "Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient." Am J Health Syst Pharm 68 (2011): 138-42. [PMID: 21200061]
399	Vasquez EM, Pollak R, Benedetti E "Clotrimazole increases tacrolimus blood levels: a drug interaction in kidney transplant patients." Clin Transplant 15 (2001): 95-9. [PMID: 11264634]
400	Venkatakrishnan K, von Moltke LL, Greenblatt DJ "Effects of the antifungal agents on oxidative drug metabolism: clinical relevance." Clin Pharmacokinet 38 (2000): 111-80. [PMID: 10709776]
401	Venkataramanan R, Zang S, Gayowski T, Singh N "Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes." Antimicrob Agents Chemother 46 (2002): 3091-3. [PMID: 12183280]
402	Wolter K, Wagner K, Philipp T, Fritschka E "Interaction between FK 506 and clarithromycin in a renal transplant patient." Eur J Clin Pharmacol 47 (1994): 207-8. [PMID: 7532134]
403	Teicher E, Vincent I, Bonhomme-Faivre L, et al. "Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 Study." Clin Pharmacokinet 46 (2007): 941-52. [PMID: 17922559]
404	Franco-Salinas G, de la Rosette JJ, Michel MC "Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations." Clin Pharmacokinet 49 (2010): 177-88. [PMID: 20170206]
405	Kamimura H, Oishi S, Matsushima H, et al. "Identification of cytochrome P450 isozymes involved in metabolism of the alpha1-adrenoceptor blocker tamsulosin in human liver microsomes." Xenobiotica 28 (1998): 909-22. [PMID: 9849639]
406	Product Information. Flomax (tamsulosin). Boehringer-Ingelheim, Ridgefield, CT.
407	Product Information. Torisel (temsirolimus). Wyeth-Ayerst Laboratories, Philadelphia, PA.
408	Abernethy DR, Greenblatt DJ, Steel K, Shader RI "Impairment of hepatic drug oxidation by propoxyphene." Ann Intern Med 97 (1982): 223-4. [PMID: 7103282]
409	Carrillo JA, Ramos SI, Herraiz AG, Llerena A, Agundez JAG, Berecz R, Duran M, Benitez J "Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients." J Clin Psychopharmacol 19 (1999): 494-9. [PMID: 10587283]
410	Fletcher GF, Kazamias TM "Cardiotoxic effects of Mellaril: conduction disturbances and supraventricular arrhythmias." Am Heart J 78 (1969): 135-8. [PMID: 5794785]
411	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
412	Greendyke RM, Gulya A "Effect of pindolol administration on serum levels of thioridazine, haloperidol, phenytoin, and phenobarbital." J Clin Psychiatry 49 (1988): 105-7. [PMID: 3346197]
413	Greendyke RM, Kanter DR "Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations." J Clin Psychopharmacol 7 (1987): 178-82. [PMID: 3597804]
414	Hartigan-Go K, Bateman DN, Nyberg G, Martensson E, Thomas SHL "Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans." Clin Pharmacol Ther 60 (1996): 543-53. [PMID: 8941027]
415	Markowitz JS, Wells BG, Carson WH "Interactions between antipsychotic and antihypertensive drugs." Ann Pharmacother 29 (1995): 603-9. [PMID: 7663034]
416	Product Information. Mellaril (thioridazine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
417	Product Information. Prozac (fluoxetine). Dista Products Company, Indianapolis, IN.
418	Silver JM, Yudofsky SC, Kogan M, Katz BL "Elevation of thioridazine plasma levels by propranolol." Am J Psychiatry 143 (1986): 1290-2. [PMID: 3766793]
419	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
420	Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
421	Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
422	Product Information. Samsca (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
423	Product Information. Vaprisol (conivaptan). Cumberland Pharmaceuticals Inc, Nashville, TN.
424	Product Information. Fareston (toremifene). Schering Laboratories, Kenilworth, NJ.
425	Machiels JP, Staddon A, Herremans C, et al. "Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studies." Cancer Chemother Pharmacol 74 (2014): 729-37. [PMID: 25100135]
426	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
427	Albert NE, Kazi S, Santoro J, Dougherty R "Ritonavir and Epidural Triamcinolone as a Cause of Iatrogenic Cushing's Syndrome." Am J Med Sci (2012):. [PMID: 22543594]
428	Dort K, Padia S, Wispelwey B, Moore CC "Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report." AIDS Res Ther 6 (2009): 10. [PMID: 19505306]
429	Fessler D, Beach J, Keel J, Stead W "Iatrogenic hypercortisolism complicating triamcinolone acetonide injections in patients with HIV on ritonavir-boosted protease inhibitors." Pain Physician 15 (2012): 489-93. [PMID: 23159966]
430	Hagan JB, Erickson D, Singh RJ "Triamcinolone Acetonide Induced Secondary Adrenal Insufficiency Related to Impaired CYP3A4 Metabolism by Coadministration of Nefazodone." Pain Med (2010):. [PMID: 20456080]
431	Hall JJ, Hughes CA, Foisy MM, Houston S, Shafran S "Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir boosted darunavir." Int J STD AIDS (2013):. [PMID: 23970582]
432	Levine D, Ananthakrishnan S, Garg A "Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy." J Am Acad Dermatol 65 (2011): 877-8. [PMID: 21920248]
433	McConkey HZ, Williams H, Kulasegaram R, Graham E "Orbital floor triamcinolone causing Cushing's syndrome in a patient treated with Kaletra for HIV 1." BMJ Case Rep 2013 (2013):. [PMID: 23440982]
434	Sadarangani S, Berg ML, Mauck W, Rizza S "Iatrogenic Cushing Syndrome Secondary to Ritonavir-Epidural Triamcinolone Interaction: An Illustrative Case and Review." Interdiscip Perspect Infect Dis 2014 (2014): 849432. [PMID: 24895495]
435	Schwarze-Zander C, Klingmuller D, Klumper J, Strassburg CP, Rockstroh JK "Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature." Infection (2013):. [PMID: 23873267]
436	Grierson MJ, Harrast MA "Iatrogenic Cushing Syndrome After Epidural Steroid Injections for Lumbar Radiculopathy in an HIV-Infected Patient Treated With Ritonavir: A Case Report Highlighting Drug Interactions for Spine Interventionalists." PM R 4 (2012): 234-7. [PMID: 22443962]
437	Ahonen J, Olkkola KT, Neuvonen PJ "Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers." Br J Clin Pharmacol 40 (1995): 270-2. [PMID: 8527290]
438	Backman JT, Kivisto KT, Olkkola KT, Neuvonen PJ "The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin." Eur J Clin Pharmacol 54 (1998): 53-8. [PMID: 9591931]
439	Barry M, Mulcahy F, Merry C, Gibbons S, Back D "Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection." Clin Pharmacokinet 36 (1999): 289-304. [PMID: 10320951]
440	Brown MW, Maldonado AL, Meredith CG, Speeg KV "Effect of ketoconazole on hepatic oxidative drug metabolism." Clin Pharmacol Ther 37 (1985): 290-7. [PMID: 3971653]
441	Decker CJ, Laitinen LM, Bridson GW, Raybuck SA, Tung RD, Chaturvedi PR "Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions." J Pharm Sci 87 (1998): 803-7. [PMID: 9649346]
442	Eagling VA, Back DJ, Barry MG "Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir." Br J Clin Pharmacol 44 (1997): 190-4. [PMID: 9278209]
443	Greenblatt DJ, von Moltke LL, Harmatz JS, et al. "Differential impairment of triazolam and zolpidem clearance by ritonavir." J Acquir Immune Defic Syndr 24 (2000): 129-36. [PMID: 10935688]
444	Greenblatt DJ, Vonmoltke LL, Harmatz JS, Harrel LM, Tobias S, Shader RI, Wright CE "Interaction of triazolam and ketoconazole." Lancet 345 (1995): 191. [PMID: 7823684]
445	Malaty LI, Kuper JJ "Drug interactions of HIV protease inhibitors." Drug Safety 20 (1999): 147-69. [PMID: 10082072]
446	Merry C, Mulcahy F, Barry M, Gibbons S, Back D "Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease." AIDS 11 (1997): 268-9. [PMID: 9030388]
447	Michalets EL "Update: clinically significant cytochrome P-450 drug interactions." Pharmacotherapy 18 (1998): 84-112. [PMID: 9469685]
448	Neuvonen PJ, Varhe A, Olkkola KT "The effect of ingestion time interval on the interaction between itraconazole and triazolam." Clin Pharmacol Ther 60 (1996): 326-31. [PMID: 8841155]
449	Olkkola KT, Backman JT, Neuvonen PJ "Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole." Clin Pharmacol Ther 55 (1994): 481-5. [PMID: 8181191]
450	Palkama VJ, Ahonen J, Neuvonen PJ, Olkkola KT "Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam." Clin Pharmacol Ther 66 (1999): 33-9. [PMID: 10430107]
451	Product Information. Halcion (triazolam). Pharmacia and Upjohn, Kalamazoo, MI.
452	Product Information. Versed (midazolam). Roche Laboratories, Nutley, NJ.
453	Product Information. Xanax (alprazolam). Pharmacia and Upjohn, Kalamazoo, MI.
454	Tsunoda SM, Velez RL, vonMoltke LL, Greenblatt DJ "Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: Effect of ketoconazole." Clin Pharmacol Ther 66 (1999): 461-71. [PMID: 10579473]
455	Varhe A, Olkkola KT, Neuvonen PJ "Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism." Br J Clin Pharmacol 41 (1996): 319-23. [PMID: 8730978]
456	Varhe A, Olkkola KT, Neuvonen PJ "Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole." Clin Pharmacol Ther 56 (1994): 601-7. [PMID: 7995001]
457	Vonmoltke LL, Greenblatt DJ, Schmider J, Duan SX, Wright CE, Harmatz JS, Shader RI "Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents." J Clin Pharmacol 36 (1996): 783-91. [PMID: 8889898]
458	Wrighton SA, Ring BJ "Inhibition of human CYP3A catalyzed 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine." Pharm Res 11 (1994): 921-4. [PMID: 7937537]
459	Greenblatt DJ, Wright CE, vonMoltke LL, Harmatz JS, Ehrenberg BL, Harrel LM, Corbett K, Counihan M, Tobias S, Shader RI "Ketoconazole inhibition of triazolam and alprazolam clearance: Differential kinetic and dynamic consequences." Clin Pharmacol Ther 64 (1998): 237-47. [PMID: 9757147]
460	Product Information. Levitra (vardenafil). Bayer, West Haven, CT.
461	Product Information. Viibryd (vilazodone). Trovis Pharmaceuticals LLC, New Haven, CT.
462	Antoniou T, Tseng AL "Interactions between antiretrovirals and antineoplastic drug therapy." Clin Pharmacokinet 44 (2005): 111-145. [PMID: 15656694]
463	Ariffin H, Omar KZ, Ang EL, Shekhar K "Severe vincristine neurotoxicity with concomitant use of itraconazole." J Paediatr Child Health 39 (2003): 638-9. [PMID: 14629538]
464	Bashir H, Motl S, Metzger ML, et al. "Itraconazole-enhanced chemotherapy toxicity in a patient with Hodgkin lymphoma." J Pediatr Hematol Oncol 28 (2006): 33-35. [PMID: 16394890]
465	Bermudez M, Fuster JL, Llinares E, Galera A, Gonzalez C "Itraconazole-related increased vincristine neurotoxicity: case report and review of literature." J Pediatr Hematol Oncol 27 (2005): 389-392. [PMID: 16012330]
466	Bohme A, Ganser A, Hoelzer D "Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL." Ann Hematol 71 (1995): 311-2. [PMID: 8534764]
467	Bosque E "Possible drug interaction between itraconazole and vinorelbine tartrate leading to death after one dose of chemotherapy." Ann Intern Med 134 (2001): 427. [PMID: 11242511]
468	Carrion C, Espinosa E, Herrero A, Garcia B "Possible vincristine-isoniazid interaction." Ann Pharmacother 29 (1995): 201. [PMID: 7756727]
469	Chan JD "Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports." Pharmacotherapy 18 (1998): 1304-7. [PMID: 9855331]
470	Chen S, Wu D, Sun A, et al "Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia." Am J Hematol 82 (2007): 942. [PMID: 17617780]
471	Corona G, Vaccher E, Spina M, Toffoli G "Potential hazard drug-drug interaction between boosted protease inhibitors and vinblastine in HIV patients with Hodgkin's lymphoma." AIDS 27 (2013): 1033-5. [PMID: 23698067]
472	Eiden C, Palenzuela G, Hillaire-Buys D, et al. "Posaconazole-increased vincristine neurotoxicity in a child: a case report." J Pediatr Hematol Oncol 31 (2009): 292-5. [PMID: 19346885]
473	Fedeli L, Colozza M, Boschetti E, et al. "Pharmacokinetics of vincristine in cancer patients treated with nifedipine." Cancer 64 (1989): 1805-11. [PMID: 2790693]
474	Gillies J, Hung KA, Fitzsimons E, Soutar R "Severe vincristine toxicity in combination with itraconazole." Clin Lab Haematol 20 (1998): 123-4. [PMID: 9681224]
475	Haddad A, Davis M, Lagman R "The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions." Support Care Cancer 15 (2007): 251-7. [PMID: 17139496]
476	Harnicar S, Adel N, Jurcic J "Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients." J Oncol Pharm Pract 15 (2009): 175-82. [PMID: 19282418]
477	Jain S, Kapoor G "Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine." Pediatr Blood Cancer 54 (2010): 783. [PMID: 20205256]
478	Jeng MR, Feusner J "Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia." Pediatr Hematol Oncol 18 (2001): 137-42. [PMID: 11255732]
479	Kajita J, Kuwabara T, Kobayashi H, Kobayashi S "CYP3A4 is mainly responsibile for the metabolism of a new vinca alkaloid, vinorelbine, in human liver microsomes." Drug Metab Dispos 28 (2000): 1121-7. [PMID: 10950859]
480	Kamaluddin M, McNally P, Breatnach F, et al "Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies." Acta Paediatr 90 (2001): 1204-7. [PMID: 11697438]
481	Kivisto KT, Kroemer HK, Eichelbaum M "The role of human cytochrome p450 enzymes in the metabolism of anticancer agents: implications for drug interactions." Br J Clin Pharmacol 40 (1995): 523-30. [PMID: 8703657]
482	Kotb R, Vincent I, Dulioust A, et al. "Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's disease." Eur J Haematol 76 (2006): 269-71. [PMID: 16451402]
483	Leveque D, Santucci R, Pavillet J, Herbrecht R, Bergerat JP "Paralytic ileus possibly associated with interaction between ritonavir/lopinavir and vincristine." Pharm World Sci 31 (2009): 619-21. [PMID: 19757141]
484	Mantadakis E, Amoiridis G, Kondi A, Kalmanti M "Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia." J Pediatr Hematol Oncol 29 (2007): 130. [PMID: 17279013]
485	Moriyama B, Falade-Nwulia O, Leung J, et al. "Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction." Mycoses 54 (2011): e877-9. [PMID: 21615537]
486	Murphy JA, Ross LM, Gibson BE "Vincristine toxicity in five children with acute lymphoblastic leukaemia." Lancet 346 (1995): 443. [PMID: 7623589]
487	Porter CC, Carver AE, Albano EA "Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X." Pediatr Blood Cancer 52 (2009): 298-300. [PMID: 18837430]
488	Product Information. Oncovin (vincristine). Lilly, Eli and Company, Indianapolis, IN.
489	Product Information. Velban (vinblastine). Lilly, Eli and Company, Indianapolis, IN.
490	Sathiapalan RK, Al-Nasser A, El-Solh H, Al-Mohsen I, Al-Jumaah S "Vincristine-itraconazole interaction: cause for increasing concern." J Pediatr Hematol Oncol 24 (2002): 591. [PMID: 12368705]
491	Sathiapalan RK, El-Solh H "Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature." Pediatr Hematol Oncol 18 (2001): 543-6. [PMID: 11764105]
492	Takahashi N, Kameoka Y, Yamanaka Y, et al. "Itraconazole oral solution enhanced vincristine neurotoxicity in five patients with malignant lymphoma." Intern Med 47 (2008): 651-3. [PMID: 18379154]
493	Tobe SW, Siu LL, Jamal SA, Skorecki KL, Murphy GF, Warner E "Vinblastine and erythromycin: an unrecognized serious drug interaction." Cancer Chemother Pharmacol 35 (1995): 188-90. [PMID: 7805175]
494	Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y "Potentiation of vincristine and adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors." Cancer Res 43 (1983): 2267-72. [PMID: 6831450]
495	van Schie RM, Bruggemann RJ, Hoogerbrugge PM, Te Loo DM "Effect of azole antifungal therapy on vincristine toxicity in childhood acute lymphoblastic leukaemia." J Antimicrob Chemother 66 (2011): 1853-6. [PMID: 21652620]
496	Yano R, Tani D, Watanabe K, et al. "Evaluation of potential interaction between vinorelbine and clarithromycin." Ann Pharmacother 43 (2009): 453-8. [PMID: 19261952]
497	Zhou XJ, Zhou-Pan XR, Gauthier T, Placidi M, Maurel P, Rahmani R "Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions." Biochem Pharmacol 45 (1993): 853-61. [PMID: 8452560]
498	Zhou-Pan XR, Seree E, Zhou XJ, et al "Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions." Cancer Res 53 (1993): 5121-6. [PMID: 8221648]
499	Product Information. Zontivity (vorapaxar). Merck & Company Inc, Whitehouse Station, NJ.
500	Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
501	Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
502	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
503	Product Information. Viramune (nevirapine). Boehringer-Ingelheim, Ridgefield, CT.
504	Product Information. Tekturna (aliskiren). Novartis Pharmaceuticals, East Hanover, NJ.
505	Tapaninen T, Backman JT, Kurkinen K, Neuvonen P, Niemi M "Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren." J Clin Pharmacol 51 (2011): 359-67. [PMID: 20400651]
506	Product Information. Axert (almotriptan) Pharmacia and Upjohn, Kalamazoo, MI.
507	Product Information. Norvasc (amlodipine). Pfizer US Pharmaceuticals, New York, NY.
508	Sasaki M, Maeda A, Fujimura A "Influence of diltiazem on the pharmacokinetics of amlodipine in elderly hypertensive patients." Eur J Clin Pharmacol 57 (2001): 85-6. [PMID: 11372598]
509	Product Information. Emend (aprepitant). Merck & Company Inc, West Point, PA.
510	Product Information. Emend for Injection (fosaprepitant). Merck & Company Inc, West Point, PA.
511	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
512	Smith DS, Fujimoto JM "Alterations produced by novobiocin during biliary excretion of morphine, morphine-3-glucuronide and other compounds." J Pharmacol Exp Ther 188 (1974): 504-15. [PMID: 4273910]
513	Suttels V, Florence E, Leys J, et al. "A 68-year old male presenting with rhabdomyolysis-associated acute kidney injury following concomitant use of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate and pravastatin/fenofibrate: a case report." J Med Case Reports 9 (2015): 190. [PMID: 26347243]
514	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
515	Busse KH, Formentini E, Alfaro RM, Kovacs JA, Penzak SR "Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals." J Acquir Immune Defic Syndr 48 (2008): 561-6. [PMID: 18645517]
516	Couturier J, Steele M, Hussey L, Pawliuk G "Steroid-induced mania in an adolescent: risk factors and management." Can J Clin Pharmacol 8 (2001): 109-12. [PMID: 11493940]
517	Finkenbine RD, Frye MD "Case of psychosis due to prednisone-clarithromycin interaction." Gen Hosp Psychiat 20 (1998): 325-6. [PMID: 9788033]
518	Garey KW, Rubinstein I, Gotfried MH, Khan IJ, Varma S, Danziger LH "Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma." Chest 118 (2000): 1826-7. [PMID: 11115481]
519	Itkin IH, Menzel ML "The use of macrolide antibiotic substances in the treatment of asthma." J Allergy Clin Immunol 45 (1970): 146-62. [PMID: 5309312]
520	Lebrun-Vignes B, Archer VC, Diquest B, et al. "Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects." Br J Clin Pharmacol 51 (2001): 443-50. [PMID: 11422002]
521	Penzak SR, Formentini E, Alfaro RM, Long M, Natarajan V, Kovacs J "Prednisolone pharmacokinetics in the presence and absence of ritonavir after oral prednisone administration to healthy volunteers." J Acquir Immune Defic Syndr 40 (2005): 573-80. [PMID: 16284534]
522	Ulrich B, Frey FJ, Speck RF, Frey BM "Pharmacokinetics/pharmacodynamics of ketoconazole-prednisolone interaction." J Pharmacol Exp Ther 260 (1992): 487-90. [PMID: 1738098]
523	Varis T, Kivisto KT, Neuvonen PJ "The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisolone." Eur J Clin Pharmacol 56 (2000): 57-60. [PMID: 10853878]
524	Yamashita SK, Ludwig EA, Middleton E Jr, Jusko WJ "Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone." Clin Pharmacol Ther 49 (1991): 558-70. [PMID: 1827622]
525	Zurcher RM, Frey BM, Frey FJ "Impact of ketoconazole on the metabolism of prednisolone." Clin Pharmacol Ther 45 (1989): 366-72. [PMID: 2639662]
526	Pekol T, Daniels JS, Labutti J, et al "Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites." Drug Metab Dispos 33 (2005): 771-7. [PMID: 15764713]
527	Product Information. Velcade (bortezomib). Millennium Pharmaceuticals Inc, Cambridge, MA.
528	Uttamsingh V, Lu C, Miwa GT, Gan LS "Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4 to the hepatic metabolism of teh protosome inhibitor bortezomib." Drug Metab Dispos 33 (2005): 1723-8. [PMID: 16103134]
529	Product Information. Buprenex (buprenorphine). Reckitt and Colman Pharmaceutical, Richmond, VA.
530	Product Information. Jevtana (cabazitaxel). sanofi-aventis , Bridgewater, NJ.
531	Product Information. Evoxac (cevimeline) Daiichi Pharmaceuticals, Fort lee, NJ.
532	Product Information. Alvesco (ciclesonide). Nycomed USA, Florham Park, NJ.
533	Product Information. Omnaris (ciclesonide nasal). Sepracor Inc, Marlborough, MA.
534	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
535	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
536	Product Information. Sensipar (cinacalcet). Amgen USA, Thousand Oaks, CA.
537	Product Information. Cleocin (clindamycin). Pharmacia and Upjohn, Kalamazoo, MI.
538	Bailey DG, Dresser GK "Natural products and adverse drug interactions." Can Med Assoc J 170 (2004): 1531-2. [PMID: 15136542]
539	Ho PC, Ghose K, Saville D, Wanwimolruk S "Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers." Eur J Clin Pharmacol 56 (2000): 693-8. [PMID: 11214778]
540	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
541	Product Information. Bevyxxa (betrixaban). Portola Pharmaceuticals, South San Francisco, CA.
542	Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
543	Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
544	Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
545	Product Information. Mavyret (glecaprevir-pibrentasvir). Abbott Pharmaceutical, Abbott Park, IL.
546	Product Information. Symproic (naldemedine). Shionogi USA Inc, Florham Park, NJ.
547	Product Information. Ofev (nintedanib). Boehringer Ingelheim, Ridgefield, CT.
548	Product Information. Wakix (pitolisant). Harmony Biosciences, LLC, Plymouth Meeting, PA.
549	Product Information. Nexletol (bempedoic acid). Esperion Therapeutics, Ann Arbor, MI.
550	Product Information. Nexlizet (bempedoic acid-ezetimibe). Esperion Therapeutics, Ann Arbor, MI.
551	Product Information. Yupelri (revefenacin). Mylan Specialty, Morgantown, WV.
552	Product Information. Nurtec ODT (rimegepant). Biohaven Pharmaceuticals, New Haven, CT.
553	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
554	Product Information. Talzenna (talazoparib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
555	Product Information. Hetlioz (tasimelteon). Vanda Pharmaceuticals Inc, Rockville, MD.
556	Product Information. Tukysa (tucatinib). Seattle Genetics Inc, Bothell, WA.
557	Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm 66 (2009): 1438-67. [PMID: 19667002]
558	Product Information. Vosevi (sofosbuvir/velpatasvir/voxilaprevir). Gilead Sciences, Foster City, CA.
559	Caraco Y, Sheller J, Wood AJJ "Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects." J Pharmacol Exp Ther 290 (1999): 413-22. [PMID: 10381807]
560	Caraco Y, Sheller J, Wood JJ "Pharmacogenetic determination of the effects of codeine and prediction of drug interactions." J Pharmacol Exp Ther 278 (1996): 1165-74. [PMID: 8819499]
561	Desmeules J, Dayer P, Gascon MP, Magistris M "Impact of genetic and environmental factors on codeine analgesia." Clin Pharmacol Ther 45 (1989): 122. [PMID: 1782973]
562	Desmeules J, Gascon MP, Dayer P, Magistris M "Impact of environmental and genetic factors on codeine analgesia." Eur J Clin Pharmacol 41 (1991): 23-6. [PMID: 1782973]
563	Hersh EV, Moore PA "Drug interactions in dentistry: the importance of knowing your CYPs." J Am Dent Assoc 135 (2004): 298-311. [PMID: 15058617]
564	Poulsen L, Brosen K, Srendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH "Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects." Eur J Clin Pharmacol 51 (1996): 289-95. [PMID: 9010701]
565	Sindrup SH, Arendt-Nielsen L, Brosen K, et al "The effect of quinidine on the analgesic effect of codeine." Eur J Clin Pharmacol 42 (1992): 587-92. [PMID: 1623898]
566	Sindrup SH, Brosen K, Bjerring P, et al. "Codeine increases pain threshold to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine." Clin Pharmacol Ther 49 (1991): 686-93. [PMID: 2249379]
567	Sindrup SH, Hofmann U, Asmussen J, Mikus G, Brosen K, Nielsen F, Ingwersen SH, Broen Christensen C "Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake." Eur J Clin Pharmacol 49 (1996): 503-9. [PMID: 8706777]
568	Thorn CF, Klein TE, Altman RB "Codeine and morphine pathway." Pharmacogenet Genomics 19 (2009): 556-8. [PMID: 19512957]
569	Vevelstad M, Pettersen S, Tallaksen C, Brors O "O-demethylation of codeine to morphine inhibited by low-dose levomepromazine." Eur J Clin Pharmacol 65 (2009): 795-801. [PMID: 19308365]
570	Zhou SF "Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II." Clin Pharmacokinet 48 (2009): 761-804. [PMID: 19902987]
571	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
572	Funck-Brentano C, Jacqz-Aigrain E, Leenhardt A, Roux A, Poirier JM, Jaillon P "Influence of amiodarone on genetically determined drug metabolism in humans." Clin Pharmacol Ther 50 (1991): 259-66. [PMID: 1914360]
573	Product Information. Qelbree (viloxazine). Supernus Pharmaceuticals Inc, Rockville, MD.
574	Product Information. Zytiga (abiraterone). Centocor Inc, Malvern, PA.
575	Darcy PF "Nutrient-drug interactions." Adverse Drug React Toxicol Rev 14 (1995): 233-54. [PMID: 8845456]
576	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
577	Product Information. Cardura (doxazosin). Pfizer US Pharmaceuticals, New York, NY.
578	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
579	Lemma GL, Desta Z, Jones DR, Gorski JC, Hall SD "Droperidol is predominantly metabolized by human CYP3A enzymes." Clin Pharmacol Ther 73 (2003): 16.
580	Product Information. Droperidol (droperidol). Abbott Pharmaceutical, Abbott Park, IL.
581	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
582	Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
583	Skinner MH, Kuan HY, Pan A, et al. "Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers." Clin Pharmacol Ther 73 (2003): 170-7. [PMID: 12621382]
584	Product Information. Duagen (dutasteride). GlaxoSmithKline Healthcare, Pittsburgh, PA.
585	Li J, Zhao M, He P, Hidalgo M, Baker SD "Differential metabolism of gefitinib and erlotinib by human cytochrome p450 enzymes." Clin Cancer Res 13 (2007): 3731-7. [PMID: 17575239]
586	Product Information. Tarceva (erlotinib). Genentech, South San Francisco, CA.
587	Product Information. Reminyl (galantamine) Janssen Pharmaceuticals, Titusville, NJ.
588	Product Information. Iressa (gefitinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
589	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
590	Product Information. Gleevec (imatinib mesylate). Novartis Pharmaceuticals, East Hanover, NJ.
591	Zeng Z, Andrew NW, Arison BH, Luffer-Atlas D, Wang RW "Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes." Xenobiotica 28 (1998): 313-21. [PMID: 9574819]
592	Product Information. Ixempra (ixabepilone). Bristol-Myers Squibb, Princeton, NJ.
593	Product Information. Vimpat (lacosamide). UCB Pharma Inc, Smyrna, GA.
594	Product Information. Chirocaine (levobupivacaine) Organon, West Orange, NJ.
595	Okubo M, Murayama N, Miura J, Chiba Y, Yamazaki H "Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients." Biochem Pharmacol 93 (2015): 104-9. [PMID: 25475885]
596	Product Information. Remeron (mirtazapine). Organon, West Orange, NJ.
597	Sitsen JM, Maris FA, Timmer CJ "Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects." Eur J Clin Pharmacol 56 (2000): 389-94. [PMID: 11009047]
598	Stormer E, von Moltke LL, Shader RI, Greenblatt DJ "Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4" Drug Metab Dispos 28 (2000): 1168-75. [PMID: 10997935]
599	Product Information. Osphena (ospemifene). Shionogi USA Inc, Florham Park, NJ.
600	Bergmann TK, Filppula AM, Launiainen T, Nielsen F, Backman J, Brosen K "Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60 year old Caucasian woman with ovarian carcinoma." Br J Clin Pharmacol (2015):. [PMID: 26446447]
601	Bun SS, Ciccolini J, Bun H, Aubert C, Catalin J "Drug interactions of paclitaxel metabolism in human liver microsomes." J Chemother 15 (2003): 266-74. [PMID: 12868554]
602	Jamis-Dow CA, Klecker RW, Katki AG, Collins JM "Metabolism of Taxol by human liver microsomes and effect of inhibitors (Meeting abstract)." Proc Annu Meet Am Assoc Cancer Res 34 (1993): a21981993.
603	Product Information. Abraxane (paclitaxel protein-bound). American Pharmaceutical Partners, Schaumberg, IL.
604	Product Information. Taxol (paclitaxel). Bristol-Myers Squibb, Princeton, NJ.
605	Spencer CM, Faulds D "Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer." Drugs 48 (1994): 794-847. [PMID: 7530632]
606	Product Information. Zemplar (paricalcitol). Abbott Pharmaceutical, Abbott Park, IL.
607	Product Information. Pomalyst (pomalidomide). QLT Phototherapeutics Inc, Vancouver, AZ.
608	Mirghani RA, Ericsson O, Tybring G, Gustafsson LL, Bertilsson L "Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man." Eur J Clin Pharmacol 59 (2003): 23-8. [PMID: 12743670]
609	Mirghani RA, Hellgren U, Bertilsson L, Gustafsson LL, Ericsson O "Metabolism and elimination of quinine in healthy volunteers." Eur J Clin Pharmacol (2003):. [PMID: 12920491]
610	Mirghani RA, Hellgren U, Westerberg PA, Ericsson O, Bertilsson L, Gustafsson LL "The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo." Clin Pharmacol Ther 66 (1999): 454-60. [PMID: 10579472]
611	Mirghani RA, Yasar U, Zheng T, et al "Enzyme kinetics for the formation of 3-hydroxyquinine and three new metabolites of quinine in vitro 3-hydroxylation by CYP3A4 is indeed the major metabolic pathway." Drug Metab Dispos 30 (2002): 1368-71. [PMID: 12433805]
612	Product Information. Qualaquin (quinine). AR Scientific Inc, Philadelphia, PA.
613	Wanwimolruk S, Paine MF, Pusek SN, Watkins PB "Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?" Br J Clin Pharmacol 54 (2002): 643-51. [PMID: 12492613]
614	Zhang H, Coville PF, Walker RJ, Miners JO, Birkett DJ, Wanwimolruk S "Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine." Br J Clin Pharmacol 43 (1997): 245-52. [PMID: 9088578]
615	Zhao XJ, Ishizaki T "A further interaction study of quinine with clinically important drugs by human liver microsomes: determinations of inhibition constant (K-i) and type of inhibition." Eur J Drug Metab Pharm 24 (1999): 272-8. [PMID: 10716067]
616	Zhao XJ, Ishizaki T "Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes." Br J Clin Pharmacol 44 (1997): 505-11. [PMID: 9384469]
617	Product Information. Rozerem (ramelteon). Takeda Pharmaceuticals America, Lincolnshire, IL.
618	Product Information. Stivarga (regorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
619	Bidstrup TB, Bjornsdottir I, Sidelmann UG, Thomsen MS, Hansen KT "CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide." Br J Clin Pharmacol 56 (2003): 305-14. [PMID: 12919179]
620	Hatorp V, Hansen KT, Thomsen MS "Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide." J Clin Pharmacol 43 (2003): 649-60. [PMID: 12817528]
621	Khamaisi M, Leitersdorf E "Severe hypoglycemia from clarithromycin-repaglinide drug interaction." Pharmacotherapy 28 (2008): 682-4. [PMID: 18447665]
622	Niemi M, Neuvonen PJ, Kivisto KT "The cytochrome P4503A4 inhibitor clarithromycin increases the plasma concentrations and effects of repaglinide." Clin Pharmacol Ther 70 (2001): 58-65. [PMID: 11452245]
623	Product Information. Prandin (repaglinide). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
624	Tornio A, Niemi M, Neuvonen M, et al. "The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: evidence for mechanism-based inhibition of CYP2C8 in vivo." Clin Pharmacol Ther 84 (2008): 403-11. [PMID: 18388877]
625	Niemi M, Backman JT, Neuvonen M, Neuvonen PJ "Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide." Diabetologia 46 (2003): 347-51. [PMID: 12687332]
626	Product Information. Istodax (romidepsin). Gloucester Pharmaceuticals, Cambridge, MA.
627	Product Information. Onglyza (saxagliptin). Bristol-Myers Squibb, Princeton, NJ.
628	Bartkowski RR, Goldberg ME, Huffnagle S, Epstein RH "Sufentanil disposition. Is it affected by erythromycin administration?" Anesthesiology 78 (1993): 260-5. [PMID: 8439020]
629	Product Information. Sufenta (sufentanil). Janssen Pharmaceutica, Titusville, NJ.
630	Product Information. Sutent (sunitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
631	Brynne N, Forslund C, Hallen B, Gustafsson LL, Bertilsson L "Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity." Br J Clin Pharmacol 48 (1999): 564-72. [PMID: 10583027]
632	Product Information. Detrol (tolterodine). Pharmacia and Upjohn, Kalamazoo, MI.
633	Product Information. Kadcyla (ado-trastuzumab). Genentech, South San Francisco, CA.
634	Dattilo PB, Nordin C "Prolonged QT associated with an overdose of trazodone." J Clin Psychiatry 68 (2007): 1309-10. [PMID: 17854263]
635	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
636	Greenblatt DJ, von Moltke LL, Harmatz JS, et al. "Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone." J Clin Pharmacol 43 (2003): 414-22. [PMID: 12723462]
637	Levenson JL "Prolonged QT interval after trazodone overdose." Am J Psychiatry 156 (1999): 969-70. [PMID: 10360146]
638	Mazur A, Strasberg B, Kusniec J, Sclarovsky S "QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination." Int J Cardiol 52 (1995): 27-9. [PMID: 8707432]
639	Product Information. Agenerase (amprenavir). Glaxo Wellcome, Research Triangle Pk, NC.
640	Product Information. Crixivan (indinavir). Merck & Co, Inc, West Point, PA.
641	Product Information. Desyrel (trazodone). Bristol-Myers Squibb, Princeton, NJ.
642	Product Information. Lexiva (fosamprenavir). GlaxoSmithKline, Research Triangle Park, NC.
643	Product Information. Oleptro (traZODone). Labopharm Inc, Laval, AL.
644	Product Information. Reyataz (atazanavir). Bristol-Myers Squibb, Princeton, NJ.
645	Product Information. Viracept (nelfinavir). Agouron Pharma Inc, La Jolla, CA.
646	Adamson PC "Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemia." Semin Hematol 31 (1994): 14-7. [PMID: 7831580]
647	Cordoba R, Ramirez E, Lei SH, et al. "Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid." Eur J Clin Pharmacol 64 (2008): 1031-2. [PMID: 18584165]
648	Dixon KS, Hassoun A "Pseudotumor cerebri due to the potentiation of all-trans retinoic acid by voriconazole." J Am Pharm Assoc (2003) 50 (2010): 742-4. [PMID: 21071321]
649	Hameed DA, el-Metwally TH "The effectiveness of retinoic acid treatment in bladder cancer: impact on recurrence, survival and TGFalpha and VEGF as end-point biomarkers." Cancer Biol Ther 7 (2008): 92-100. [PMID: 18347417]
650	Kizaki M, Ueno H, Yamazoe Y, et al "Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein." Blood 87 (1996): 725-33. [PMID: 8555497]
651	Lotan Y, Lotan R "Prevention of bladder cancer recurrence by retinoic acid-ketoconazole: a promising strategy?" Cancer Biol Ther 7 (2008): 101-2. [PMID: 18347420]
652	Marill J, Cresteil T, Lanotte M, Chabot GG "Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites." Mol Pharmacol 58 (2000): 1341-8. [PMID: 11093772]
653	Moresco G, Martinello F, Souza LC "[Acute renal failure in patient treated with ATRA and amphotericin B: case report]." J Bras Nefrol 33 (2011): 276-81. [PMID: 21789447]
654	Muindi JRF, Young CW, Warrell RP "Clinical pharmacology of all-trans retinoic acid." Leukemia 8 (1994): 1807-12. [PMID: 7967726]
655	Product Information. Vesanoid (tretinoin). Roche Laboratories, Nutley, NJ.
656	Rigas JR, Francis PA, Muindi JR, Kris MG, Huselton C, DeGrazia F, Orazem JP, Young CW, Warrell RP Jr "Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole." J Natl Cancer Inst 85 (1993): 1921-6. [PMID: 8230282]
657	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
658	Product Information. Effexor (venlafaxine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
659	Nakasa H, Nakamura H, Ono S, Tsutsui M, Kiuchi M, Ohmori S, Kitada M "Prediction of drug-drug interactions of zonisamide metabolism in humans from in vitro data." Eur J Clin Pharmacol 54 (1998): 177-83. [PMID: 9626925]
660	Product Information. Zonegran (zonisamide) Elan Pharmaceuticals, S. San Francisco, CA.
661	Product Information. Letairis (ambrisentan). Gilead Sciences, Foster City, CA.
662	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
663	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
664	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
665	Product Information. Pifeltro (doravirine). Merck & Company Inc, Whitehouse Station, NJ.
666	Product Information. Xerava (eravacycline). Tetraphase Pharmaceuticals, Inc, Watertown, MA.
667	Product Information. Akynzeo (netupitant-palonosetron). Eisai Inc, Woodcliff Lake, NJ.
668	Product Information. Tivicay (dolutegravir). ViiV Healthcare, Research Triangle Park, NC.
669	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
670	Rojas-Fernandez C, Fisher C "Drug interactions and donepezil." J Am Geriat Soc 40 (2000): 597-8. [PMID: 10811561]
671	Tiseo PJ, Perdomo CA, Friedhoff LT "Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses." Br J Clin Pharmacol 46 (1998): 30-4. [PMID: 9839763]
672	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
673	Product Information. Myrbetriq (mirabegron). Astellas Pharma US, Inc, Deerfield, IL.
674	Product Information. Elidel (pimecrolimus topical). Novartis Pharmaceuticals, East Hanover, NJ.
675	Product Information. Altabax (retapamulin topical). GlaxoSmithKline, Research Triangle Park, NC.
676	Ekstrom G, Gunnarsson UB "Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes." Drug Metab Dispos 24 (1996): 955-61. [PMID: 8886604]
677	Halldin MM, Bredberg E, Angelin B, Arvidsson T, Askemark Y, Elofsson S, Widman M "Metabolism and excretion of ropivacaine in humans." Drug Metab Dispos 24 (1996): 962-8. [PMID: 8886605]
678	Jokinen MJ, Ahonen J, Neuvonen PJ, Olkkola KT "The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine." Anesth Analg 91 (2000): 1207-12. [PMID: 11049910]
679	McClure JH "Ropivacaine." Br J Anaesth 76 (1996): 300-7. [PMID: 8777115]
680	Oda Y, Furuichi K, Tanaka K, Hiroi T, Imaoka S, Asada A, Fujimori M, Funae Y "Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450." Anesthesiology 82 (1995): 214-20. [PMID: 7832304]
681	Product Information. Naropin (ropivacaine). Astra USA, Westborough, MA.
682	Arlander E, Ekstrom G, Alm C, Carrillo JA, Bielenstein M, Bottiger Y, Bertilsson L, Gustafsson LL "Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors." Clin Pharmacol Ther 64 (1998): 484-91. [PMID: 9834040]
683	Miceli JJ, Smith M, Robarge L, Morse T, Laurent A "The effects of ketoconazole on ziprasidone pharmacokinetics--a placebo-controlled crossover study in healthy volunteers." Br J Clin Pharmacol 49(suppl 1) (2000): s71-6. [PMID: 10771458]
684	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
685	Wilner KD, Hansen RA, Folger CJ, Geoffroy P "The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid." Br J Clin Pharmacol 49(Suppl 1) (2000): 57S-60S. [PMID: 10771455]
686	Prakash C, Kamel A, Cui D, Whalen RD, Miceli JJ, Tweedie D "Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions." Br J Clin Pharmacol 49(Suppl 1) (2000): 35S-42S. [PMID: 10771452]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence